cytarabine and Local Neoplasm Recurrence

cytarabine has been researched along with Local Neoplasm Recurrence in 370 studies

Research

Studies (370)

Timeframe	Studies, this research(%)	All Research%
pre-1990	48 (12.97)	18.7374
1990's	54 (14.59)	18.2507
2000's	88 (23.78)	29.6817
2010's	122 (32.97)	24.3611
2020's	58 (15.68)	2.80

Authors

Authors	Studies
de Lima, VCC; Filho, JS; Germano, JN; Matias Vieira, GM; Moura, FL; Sapelli, J	1
Alonzo, TA; Aplenc, R; de Bont, ESJM; Gamis, AS; Gerbing, RB; Hoff, FW; Horton, TM; Jenkins, GN; Kolb, EA; Kornblau, SM; Meshinchi, S; Qiu, Y; van Dijk, AD	1
Thol, F	1
Burnett, A; Dennis, M; Hills, R; Kjeldsen, L; Russell, N	1
Ashkenazi, M; Avni, B; Grisariu, S; Lebel, E; Stepensky, P; Vainstein, V; Zimran, E	1
Bhar, S; Carrum, G; Craddock, J; Doherty, EE; Friend, BD; Heslop, HE; Hill, LC; John, TD; Kamble, RT; Krance, RA; Lulla, P; Martinez, C; Muhsen, IN; Patel, S; Pingali, SR; Ramos, CA; Salem, B; Sasa, G; Wang, T; Wu, M	1
Chen, J; Fang, Q; Gong, B; Gong, X; Gu, R; Jin, J; Li, Y; Lin, D; Liu, B; Liu, K; Liu, Y; Mi, Y; Qiu, S; Song, Z; Wang, J; Wang, Y; Wei, H; Wei, S; Yang, M; Zhang, G; Zhang, J; Zhou, C	1
Borawska, A; Chełstowska, M; Dąbrowska-Iwanicka, A; Domańska-Czyż, K; Druzd-Sitek, A; Giebel, S; Knopińska-Posłuszny, W; Konecki, R; Kumiega, B; Lange, A; Malenda, A; Michalski, W; Mordak-Domagała, M; Najda, J; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Pluta, A; Popławska, L; Romejko-Jarosińska, J; Rymkiewicz, G; Świerkowska, M; Szpila, T; Szymański, M; Targoński, Ł; Taszner, M; Walewski, J; Zaucha, JM	1
Bashey, A; Brown, S; Holland, HK; Jackson, KC; Morris, LE; Shegda, N; Solh, M; Solomon, SR; Zhang, X	1
Bhojwani, D; Burke, MJ; Chao, K; Colace, SI; Doan, A; Gossai, NP; Guinipero, T; Hilsenbeck, SG; Hinson, A; Jo, E; Kaplan, JA; Otterson, D; Pommert, L; Schafer, ES; Stevens, AM; Wayne, AS	1
Fu, Y; Gui, R; Guo, S; Li, Z; Song, Y; Wang, X; Zhan, X; Zhang, B; Zhang, W; Zhang, Y; Zhou, J; Zu, Y	1
Adachi, H; Atsuta, Y; Doki, N; Hashimoto, S; Igarashi, A; Kaito, S; Kishida, Y; Kito, S; Kobayashi, T; Konishi, T; Konuma, R; Marumo, A; Mukae, J; Murofushi, KN; Nagata, A; Najima, Y; Noguchi, Y; Ogawa, H; Ohashi, K; Shimizu, H; Shingai, N; Toya, T; Wada, A; Yamada, Y	1
Billingham, L; Craddock, C; Dillon, R; Fox, S; Freeman, S; Hemmaway, C; Homer, E; Jackson, A; Knapper, S; Leahy, J; Mamwell, A; Maycock, S; Ommen, HB; Potter, N; Russell, N; Thomas, C; Wei, A	1
Cheng, Q; Hou, M; Li, L; Li, T; Yu, J; Zha, S; Zheng, Q	1
Alanne, E; Harmanen, M; Hujo, M; Jantunen, E; Jukkola, A; Kari, E; Khan, M; Klaavuniemi, T; Kuittinen, O; Kuitunen, H; Prusila, R; Rajamäki, A; Rönkä, A; Sancho, JM; Sorigue, M; Sund, R; Sunela, K	1
Appelbaum, J; Curley, N; Estey, EH; Gooley, T; Halpern, AB; Hendrie, PC; Kopmar, NE; Lim, J; Percival, MM; Russell, K; Schonhoff, K; Scott, BL; Shaw, C; Walter, RB	1
Bhalla, KN; Birdwell, CE; Das, K; Daver, N; Davis, JA; DiNardo, CD; Fiskus, W; Kadia, TM; Kantarjian, H; Loghavi, S; McGeehan, GM; Mill, CP; Ruan, X; Sasaki, K; Su, X; Takahashi, K	1
Chang, J; Jin, J; Shen, YJ; Wang, HF; Ye, XN; Zhang, Y; Zhu, HH; Zhu, L	1
Bao, HZ; Cai, QQ; Dong, YJ; He, J; Huang, WR; Jing, HM; Li, LH; Li, XL; Li, ZL; Liu, AC; Liu, H; Liu, SZ; Sun, XH; Wang, JW; Wang, SY; Wang, YL; Xiao, XB; Yang, P; Yang, W; Zhang, W	1
Arcari, A; Botto, B; Bruna, R; Celli, M; Cencini, E; Chini, C; Di Rocco, A; Evangelista, A; Ferrante, M; Ferrero, S; Ghiggi, C; Merli, F; Moia, R; Patti, C; Pileri, SA; Puccini, B; Quaglia, FM; Re, A; Sciarra, R; Spina, M; Stelitano, C; Tani, M; Tisi, MC; Visco, C; Volpetti, S; Zambello, R; Zanni, M; Zilioli, VR	1
Bartlett, NL; Cashen, A; Edwin, N; Fehniger, TA; Ghobadi, A; Guy, DG; Kahl, BS; Patel, DA; Shah, NM; Trinkaus, K; Wan, F; Watkins, M	1
Basara, N; Benner, A; Bullinger, L; Cocciardi, S; Döhner, H; Döhner, K; Fiedler, W; Fransecky, L; Gaidzik, VI; Ganser, A; Götze, K; Greil, R; Hertenstein, B; Heuser, M; Kapp-Schwoerer, S; Koller, E; Krauter, J; Krzykalla, J; Kühn, MWM; Leis, C; Lübbert, M; Machherndl-Spandl, S; Martens, UM; Mayer, K; Nachbaur, D; Paschka, P; Ringhoffer, M; Saadati, M; Samra, MA; Schleicher, J; Schlenk, RF; Schrade, A; Schroeder, T; Thol, F; Wattad, M; Weber, D; Wulf, G	1
Baidildina, D; Bronin, G; Burtsev, E; Cherniak, E; Dzhukaeva, I; Erega, E; Evseev, D; Fink, O; Ignatova, A; Kalinina, I; Kotskaya, N; Litvin, E; Lyudovskikh, E; Maschan, A; Maschan, M; Novichkova, G; Osipova, D; Popov, A; Pristanskova, E; Purbueva, B; Raykina, E; Semchenkova, A; Vlasova, I; Voronin, K; Zhogov, V	1
Byun, JM; Choi, YS; Do, YR; Hong, J; Kim, DS; Kim, I; Kim, KH; Kim, WS; Koh, Y; Lee, GW; Lee, JY; Park, Y; Shin, J; Yoon, SS	1
Ahern, K; Correia De Farias, M; Pham, J; Sanderson, R; Walsh, K	1
Ballerini, F; Cagnetta, A; Canale, F; Cea, M; Clavio, M; Coviello, E; Giannoni, L; Gobbi, M; Guolo, F; Lemoli, RM; Manconi, L; Marcolin, R; Miglino, M; Minetto, P	1
Bañuelos-Ávila, AJ; Barrera-Chairez, E; Fernandez-Vargas, OE; Ron-Guerrero, CS; Ron-Magaña, AL	1
Jayakumar, I; Patel, S; Raj, R; Ramakrishnan, B; Ramanan, KM; Ravichandran, N; Swaminathan, VV; Uppuluri, R	1
Chen, K; Jiang, H; Li, H; Shao, JB; Yang, JW; Zhang, N; Zhu, JS	1
Arthur, C; Coyle, L; Enjeti, A; Fay, K; Greenwood, M; Jeffrey, A; Katsioulas, V; Kerridge, I; Mackinlay, N; Nalpantidis, A; Shortt, J; Stevenson, W; Yip, E	1
Hagiwara, S; Nagai, H; Okada, S; Saito, AM; Uehira, T	1
Barlogie, B; Mouhieddine, TH; Teruya-Feldstein, J	1
Crosbie, N; Eyre, TA; Frewin, R; Lambert, J; McCulloch, R; McMillan, A; Phillips, N; Quaglia, FM; Rule, S; Tucker, DL; Visco, C	1
Beham-Schmid, C; Deutsch, A; Greinix, H; Hatzl, S; Neumeister, P; Pichler, M; Posch, F; Prochazka, KT; Stöger, H	1
An, HY; Choi, HJ; Choi, JY; Hong, KT; Kang, HJ; Kim, BK; Shin, HY	1
Arens, AIJ; Brice, P; Burggraaff, CN; De Jong, D; Diepstra, A; Driessen, J; Gastinne, T; Hagenbeek, A; Hutchings, M; Kersten, MJ; Liu, R; Lopez-Yurda, M; Lugtenburg, PJ; Morschhauser, F; Nijland, M; Plattel, WJ; Tonino, SH; Valkema, R; van Tinteren, H; Zijlstra, JM	1
Bertrand, Y; Girard, S; Marceau-Renaut, A; Penel-Page, M; Plesa, A; Renard, C	1
Apel, A; Cohen, Y; Danylesko, I; Ganzel, C; Gino-Moor, S; Gural, A; Koren-Michowitz, M; Moshe, Y; Nachmias, B; Ofran, Y; Pasvolsky, O; Peretz, G; Ram, R; Rowe, JM; Vainstein, V; Wolach, O; Yeganeh, S; Yerushalmi, R; Zektser, M	1
Liu, L; Tan, L; Xie, Y; Yang, J	1
Allen, K; Castellino, SM; Cooper, TM; Keller, FG; Metts, JL; Minson, KA; Monroe, C; Sabnis, HS; Woods, WG	1
Adachi, S; Goto, H; Hasegawa, D; Iwamoto, S; Kakuda, H; Koh, K; Miyamura, T; Moritake, H; Nakayama, H; Saito, A; Shiba, N; Shimada, A; Taga, T; Tanaka, S; Terui, K; Tomizawa, D; Yuza, Y	1
Avivi, I; Blumenthal, DT; Bokstein, F; Gibstein, L; Perry, C; Ram, R; Sarid, N; Weiss-Meilik, A	1
Blackwood, L; Harper, A; Smallwood, K	1
Böhmová, E; Etrych, T; Helman, K; Karolová, J; Klener, P; Pankrác, J; Pechar, M; Pokorná, E; Pola, R; Šefc, L; Trněný, M; Vočková, P	1
Bai, J; Lian, X; Pei, Z; Song, Q; Wang, H; Wang, J; Zhang, B	1
Ai, WZ; Andreadis, CB; Damon, L; Fakhri, B; Huang, CY; Hunter, B; Kambhampati, S; Kaplan, L; Martin, T; Pampaloni, M; Varnavski, A	1
Leach, M; McKay, P; Oun, H; Wilson, M	1
Gu, W; Hua, X; Ling, Y; Wang, B; Yan, F; Yang, B; Zhang, J	1
Chen, HQ; Fang, JP; Li, CG; Li, CK; Li, JQ; Li, XY; Lin, YD; Liu, RY; Luo, XQ; Sun, X; Sun, XF; Wu, XD; Xu, HG	1
Chen, XJ; Chen, YM; Guo, Y; Liu, F; Liu, LP; Liu, TF; Liu, XM; Quan Qi, B; Ruan, M; Yang, WY; Zhang, AL; Zhang, L; Zhu, XF; Zou, Y	1
Giordano, C; Picardi, M	1
Abedi, M; Hoeg, RT; Jonas, BA; Krishnan, R; Moskoff, BN; Rosenberg, AS; Tenold, ME; Tuscano, JM	1
Chandra Sekaran, U; Grove, CS	1
Acuña-Cruz, E; Barragán, E; Bergua, JM; Boluda, B; Cano-Ferri, I; Martín-Herreros, B; Martínez Sánchez, MP; Martínez-Cuadrón, D; Martínez-López, J; Megías-Vericat, JE; Montesinos, P; Rodríguez-Veiga, R; Sanz, M; Sargas, C; Sempere, A; Serrano, A; Suárez-Varela, S; Torrent, A; Torres-Miñana, L; Vives, S	1
Bertram, S; Dührsen, U; Ganser, A; Hüttmann, A; Ibach, S; Kroschinsky, F; Tometten, M	1
Adeoti, M; Alvarado, Y; Andreeff, M; Borthakur, G; Daver, N; DiNardo, CD; Garcia-Manero, G; Issa, G; Jabbour, E; Jain, N; Kadia, T; Kantarjian, HM; Konopleva, MY; Kornblau, S; Lachowiez, CA; Loghavi, S; Maiti, A; Masarova, L; Montalban Bravo, G; Pemmaraju, N; Ravandi, F; Sasaki, K; Short, NJ; Takahashi, K; Wang, S; Xiao, L; Yilmaz, M	1
Birkmann, J; Blaudszun, AR; Bornhäuser, M; Ehninger, G; Fiedler, F; Fricke, S; Hänel, A; Hänel, M; Herbst, R; Kroschinsky, F; Kürzel, S; Schaefer-Eckart, K; Stahl, L	1
Gergis, U; Grosso, D	1
Balsat, M; Barraco, F; Baudouin, A; Cadassou, O; Ducastelle, S; Elhamri, M; Fossard, G; Gutrin, J; Hayette, S; Heiblig, M; Labussière, H; Larcher, MV; Plesa, A; Roumier, C; Sujobert, P; Thomas, X; Tigaud, I	1
Absalon, MJ; Ahmed, A; August, K; Baker, SD; Boklan, J; Brown, PA; Cooper, TM; Gore, L; Li, L; Macy, ME; Magoon, D; Narendran, A; Pollard, J; Sison, EAR; Trippett, T	1
Borthakur, G; Brandt, M; Cortes, JE; Daver, NG; DiNardo, CD; Estrov, Z; Gandhi, V; Garcia-Manero, G; Huang, X; Jabbour, E; Jain, N; Kadia, TM; Kantarjian, H; Konopleva, M; O'Brien, SM; Pemmaraju, N; Plunkett, W; Ravandi, F; Sasaki, K; Short, NJ; Wierda, WG; Xiao, L	1
Guo, J; Parasramka, S; Rosenfeld, M; Talari, G; Villano, JL	1
Isaac McGraw, B; Savaşan, S; Sweeney, C	1
Kang, Q; Londoño-Joshi, A; Malek, SN; Parkin, B; Rhim, AD; Tewari, M	1
Blackford, AL; Doyle, LA; Gojo, I; Huntoon, CJ; Karnitz, LM; Karp, JE; Kaufmann, SH; Kinders, R; Litzow, M; Morris, L; Patnaik, M; Rosner, GL; Smith, BD; Tibes, R; Wang, L; Webster, JA	1
Fang, B; Fu, Y; Liu, X; Song, Y; Wei, X; Yu, F; Zhang, Y; Zhou, H; Zhou, J; Zhou, K	1
Cubitt, C; Komrokji, RS; Lancet, JE; List, AF; Mirza, AS; Nardelli, L; Padron, E; Pinilla-Ibarz, J; Sweet, K	1
Altuntaş, F; Ayyildiz, MO; Bekdemir, F; Çakar, MK; Dal, MS; Dogu, MH; Hacioglu, SK; Ilkkiliç, K; Karakus, A; Kaya, AH; Korkmaz, S; Merdin, A; Tekgündüz, E	1
Alenxandrova, K; Arfi-Rouche, J; Bourhis, JH; Castilla-Llorente, C; Danu, A; Ghez, D; Khalife-Saleh, N; Koscielny, S; Lapierre, V; Lazarovici, J; Legoupil, C; Michot, JM; Pilorge, S; Ribrag, V; Saleh, K	1
Anwer, F; Guillén-Rodríguez, JM; Heard, K; Inclán, L; Mahadevan, D; Persky, DO; Puvvada, SD; Rivera, XI; Schatz, JH; Yan, J	1
Fanale, M; Fayad, LE; Feng, L; Ford, P; Fowler, N; Goy, A; Hagemeister, F; Hartig, K; Kantarjian, HM; Kwak, LW; McLaughlin, P; Medeiros, LJ; Naig, A; Neelapu, S; Oki, Y; Orlowski, R; Pro, B; Rodriguez, MA; Romaguera, JE; Samaniego, F; Smith, J; Valentinetti, M; Wang, M; Younes, A	1
Berard, E; Bertoli, S; Gadaud, N; Huguet, F; Huynh, A; Luquet, I; Récher, C; Sarry, A; Tavitian, S	1
Cao, K; Cao, P; Huang, C; Li, X; Liu, L; Tian, R; Wang, L; Wu, H; Xu, C; Zhu, H	1
Che, F; Gui, C; Huang, J; Wang, C; Zhang, L	1
An, R; Hu, K; Jing, HM; Ke, XY; Liu, YY; Pang, M; Wan, W; Yang, P; Zhao, W; Zhen, JF	1
Hale, G; Kussman, A; Oshrine, B; Petrovic, A; Shyr, D	1
Beltran, BE; Conlon, K; Cook, L; Dwyer, K; Feldman, T; Fields, PA; Gonsky, J; Hermine, O; Horwitz, SM; Humphrey, J; Kurman, M; Leoni, M; Moriya, J; Pereira, J; Phillips, AA; Ramos, JC; Sawas, A; Taylor, GP; Wandroo, F	1
Arnall, J; Griffin, S; Hargett, C; Hatley, C; Hill, H; Howell, T; Janes, A; Larck, C; Park, S; Swift, K	1
Caballero, MD; Canales, M; de la Cruz, F; Domingo-Domenech, E; Garcia-Sanz, R; Gonzalez, AP; Gutierrez, A; Jimenez-Cabrera, S; Lopez, J; Martinez, C; Moreno, M; Pinana, JL; Rodriguez, A; Rodriguez, G; Rodriguez-Salazar, MJ; Sanchez-Gonzalez, B; Sureda, A	1
Amores-Fuster, I; Blackwood, L; Elliott, J; Finotello, R; Grant, IA; Harper, A; Killick, DR; Marrington, M; Mas, A; Smallwood, K; Tanis, JB	1
Fukui, T; Goto, M; Hakiri, S; Hashimoto, K; Ito, T; Kawaguchi, K; Mori, S; Nakamura, S; Ozeki, N; Yokoi, K	1
Gibson, B; Huang, F; Kearns, P; Moreno, L; Nakahara, S; Nemat, S; Nysom, K; Parasrampuria, DA; Reinhardt, D; Zhou, W; Zwaan, CM	1
Campbell, J; Ernst, D; Hurtado, S; Kutz, C; Soto, K	1
Hu, Y; Huang, H; Jin, A; Jin, M; Luo, Y; Tan, Y; Wei, G; Wu, W; Yang, L; Yu, J	1
Kamimura, R; Kanemoto, Y; Kashima, S; Koyama, T; Miyamoto, K; Miyanaga, H; Oishi, T; Sakahira, H; Soyama, H; Takahashi, H; Watanabe, A	1
Andreassen, PR; Bu, J; Chen, W; Dong, Y; Feng, X; Hayashi, Y; Huang, G; Huang, R; Ju, Z; Wang, J; Wang, QF; Xiao, Z; Xu, Z; Yan, X; Zhan, D; Zhang, Y; Zhao, T; Zhao, X; Zhou, Y	1
Bishton, M; Campbell, R; Cheah, CY; Cochrane, T; De Mel Widanalage, S; Gilbertson, M; Hapgood, G; Hawkes, E; Hill, K; Johnston, A; Lee, HP; Manos, K; Nelson, N; Ng, M; Ng, ZY; Opat, S; Poon, M; Purtill, D; Ratnasingam, S; Ritchie, D; Schwarer, A; Seymour, J; Shorten, S; Sunny, T; Tam, C; Xin, L	1
Advani, AS; Caimi, P; Carew, J; Carraway, H; Chan, R; Cooper, B; de Lima, M; Elson, P; Gerds, A; Hamilton, B; Kalaycio, M; Little, J; Maciejewski, J; Malek, E; Miron, A; Mukherjee, S; Nazha, A; Pink, J; Sekeres, MA; Sobecks, R; Tomlinson, B; Unger, A; Visconte, V; Wei, W	1
Atsuta, Y; Emi, N; Fujimaki, K; Fujisawa, S; Fujita, H; Kobayashi, Y; Maeda, A; Miyazaki, Y; Naoe, T; Ohtake, S; Ohwada, A; Sunami, K; Takeshita, A; Taniwaki, M; Tsuboi, K; Tsuzuki, M; Yanada, M	1
Abikhair, M; Arumugaswamy, A; Bajel, A; Chan, KL; Cher, L; Gregory, G; Grigg, A; Leung, T; Opat, S; Ritchie, D; Tam, C	1
Aslan, D; Cetin, M; Eroglu, C; Eser, B; Kaynar, L; Keklik, M; Kurnaz, F; Mentes, S; Orhan, O; Sahin, C; Sivgin, S; Soyuer, S; Unal, A; Yildiz, OG	1
Bembnista, E; Czyz, A; Dytfeld, D; Gil, L; Kazmierczak, M; Komarnicki, M; Kozlowska-Skrzypczak, M; Lojko-Dankowska, A; Matuszak, M; Nowicki, A	1
Dreyling, M; Hess, G; Memmer, ML; Witzens-Harig, M	1
Burger, JA; Challagundla, P; Champlin, RE; Cortes, JE; Estrov, Z; Faderl, S; Ferrajoli, A; Garris, R; Huang, X; Jorgensen, JL; Kantarjian, HM; Kebriaei, P; Luthra, R; O'Brien, S; Ravandi, F; Thomas, DA; Wang, SA; Wen, S	1
Drach, J; Kiesewetter, B; Lamm, W; Mayerhöfer, ME; Müllauer, L; Raderer, M; Zielinksi, CC	1
Go, A; Guo, R; Parthasarathy, M; Rodriguez, T; Smith, S; Sobol, U; Stiff, P; Vimr, R	1
Dzietczenia, J; Fornagiel, S; Jurczak, W; Kumiega, B; Skotnicki, AB	1
Blum, W; Byrd, JC; Chan, KK; Devine, SM; Grever, MR; Huynh, L; Kefauver, C; Klisovic, RB; Liu, Z; Marcucci, G; Xie, Z; Zwiebel, JA	1
Handa, H; Hatsumi, N; Jimbo, T; Miyawaki, S; Nojima, Y; Saitoh, T; Sakura, T; Shimizu, H; Takada, S	1
Chen, XH; Gao, L; Gong, Y; Zhang, C; Zhang, X	1
Chen, L; Du, J; Li, M; Li, Y; Mi, R; Wei, X; Yin, Q	1
Azzarà, A; Benedetti, E; Buda, G; Caracciolo, F; Carulli, G; Fontanelli, G; Galimberti, S; Orciuolo, E; Petrini, M; Rocco, M	1
Asou, N; Emi, N; Horikawa, K; Iwanaga, M; Kimura, Y; Kishimoto, Y; Kiyoi, H; Matsuda, M; Monma, F; Nakaseko, C; Naoe, T; Ohtake, S; Okada, M; Ono, T; Shinagawa, K; Takahashi, M; Takeshita, A; Yamauchi, T	1
Díaz-Llopis, M; España-Gregori, E; Hernández-Martínez, P; Hervás-Ontiveros, A; Vera-Sempere, FJ	1
Arnold, R; Bilger, K; Blaise, D; Bunjes, D; Chevallier, P; Cornelissen, JJ; Craddock, C; Fegueux, N; Goker, H; Kuball, J; Labopin, M; Maertens, J; Mohty, M; Nagler, A; Schouten, HC; Sengeloev, H; Socie, G; Vindelov, L; Yeshurun, M	1
Kato, K; Matsumoto, K; Matsuyama, T; Yoshida, N	1
Anderson, CM; de Magalhaes Silverman, M; Hoffman, HT; Hoover, AC; Smith, MC; Syrbu, SI	1
Ardeshna, KM; Bird, A; Goldstone, AH; Kothari, J; Lambert, J; Linch, DC; Morris, E; Peggs, KS; Thomson, KJ; Virchis, AE	1
Cui, J; Gao, S; Han, W; Li, W; Liu, X; Su, L; Tan, Y; Yu, P	1
Axtell, R; Beuschel, NL; Cherba, DM; Davidson, PJ; Dylewski, D; Eugster, E; Junewick, JJ; Lester, EP; Mitchell, D; Monks, NR; Monsma, DJ; Rangarajan, S; Richardson, PJ; Scott, SB; Vance, S; Webb, CP	1
Fix, P; Fricke, HJ; Glaser, A; Hochhaus, A; La Rosée, P; Schnetzke, U; Scholl, S; Schrenk, K; Spies-Weisshart, B	1
Barisone, E; Berger, M; Cesaro, S; De Matteo, A; Locatelli, F; Menna, G; Messina, C; Micalizzi, C; Morello, W; Parasole, R; Pession, A; Petruzziello, F; Poggi, V; Testi, AM; Varotto, S	1
Adlard, K; Alonzo, TA; Ballard, J; Gamis, AS; Gerbing, RB; Horton, TM; Howard, DS; Jenkins, G; Kelder, A; Moscow, JA; Perentesis, JP; Schuurhuis, GJ; Smith, FO	1
Biron, P; Bouabdallah, R; Boumendil, A; Cahn, JY; Colombat, P; Cook, G; Cordonnier, C; Dreger, P; El-Najjar, I; Ferrant, A; Finel, H; Gribben, J; Haynes, AP; Luan, JJ; Mohty, M; Montoto, S; Pfreundschuh, M; Sureda, A; Thomson, K; Tilly, H; Vernant, JP	1
Allan, JM; Cole, M; Fordham, SE; Irving, JA	1
Nagai, H	1
Chen, T; Craig, AR; Cripe, LD; Fox, JA; Hawtin, R; Karp, JE; Lancet, JE; Leavitt, RD; Maris, MB; Michelson, GC; Ravandi, F; Roboz, GJ; Stuart, RK	1
Assouline, S; Bergeron, J; Borden, KL; Caplan, S; Cocolakis, E; Culjkovic-Kraljacic, B; Lambert, C; Lau, CJ; Miller, WH; Zahreddine, HA	1
Creutzig, U; Kaspers, GL; Reinhardt, D; Semmler, J; Zimmermann, M	1
Kotsianidis, I; Tsatalas, C	1
Ando, K; Kikuchi, T; Kikuti, YY; Kojima, M; Moriuchi, M; Murayama, H; Nakamura, N; Ogawa, Y; Tokunaka, M; Tsuboi, K; Yabe, M	1
Ichikawa, M; Kogure, Y; Kurokawa, M; Nakamura, F; Nannya, Y; Ueda, K; Yoshimi, A	1
Fornagiel, S; Giebel, S; Giza, A; Jurczak, W; Komarnicki, M; Kroll-Balcerzak, R; Kumiega, B; Machaczka, M; Ogórka, T; Rybka, J; Skotnicki, AB; Wróbel, T	1
Abdel-Wahab, O; Estey, EH; Fernandez, HF; Gönen, M; Lee, JW; Levine, RL; Othus, M; Paietta, EM; Patel, J; Racevskis, J; Sun, Z; Tallman, MS; Walter, RB	1
Burnett, AK; Clark, RE; Dennis, M; Dignum, H; Hemmaway, C; Hills, RK; Kjeldsen, L; McMullin, MF; Milligan, D; Panoskaltsis, N; Russell, N; Thomas, IF	1
Esiashvili, N; Flowers, CR; Jegadeesh, N; Khan, MK; Liu, Y; Okwan-Duodu, D; Rajpara, R; Shi, Z	1
Aulitzky, W; Bornhäuser, M; Ehninger, G; Fiedler, F; Hänel, A; Hänel, M; Herbst, R; Kroschinsky, F; Lange, T; Maschmeyer, G; Morgner, A; Neugebauer, S; Niederwieser, D; Peter, N; Pönisch, W; Schäfer-Eckart, K; Schetelig, J; Schulze, A; Thiel, A; Wilhelm, M	1
Arellano-Galindo, J; Bekker-Méndez, VC; Dueñas-González, MT; García-Jiménez, X; Jaimes-Reyes, EZ; Jiménez-Hernández, E; Marín-Palomares, T; Martínez Villegas, O; Mejía-Aranguré, JM; Ortíz-Fernández, A; Ortíz-Torres, MG; Sánchez-Jara, B; Tiznado-García, HM	1
Aoki, K; Aotsuka, N; Arai, Y; Atsuta, Y; Kato, K; Kondo, T; Kouzai, Y; Nakamae, H; Nakaseko, C; Onishi, Y; Ota, S; Ozawa, Y; Takahashi, S; Takami, A; Takeda, J; Yamaguchi, H	1
Kato, T; Komiya, A; Kondo, F; Nomura, K; Wakisaka, M	1
Anacak, Y; Aydinok, Y; Balkan, C; Delcastello, BE; Kamer, SA; Karadaş, N; Karapinar, DY; Kavakli, K	1
Bornhäuser, M	1
Acton, G; Carella, AM; Cortes, J; Craig, AR; Craig, MD; Damon, L; Derigs, HG; Erba, HP; Fox, JA; Gaidano, G; Havelange, V; Heuser, M; Hogge, D; Horst, HA; Jabbour, E; Kantarjian, HM; Klimek, VM; Lancet, JE; Maertens, J; Mehta, C; Odenike, O; Pigneux, A; Powell, BL; Ravandi, F; Recher, C; Ritchie, EK; Roboz, GJ; Sayar, H; Schiller, GJ; Smith, JA; Strickland, SA; Stuart, RK; Thomas, X; Vey, N; Ward, R; Wei, A	1
Carter, BZ; Dai, M; Ding, B; Jiang, L; Jiang, X; Liang, S; Liu, Q; Meng, F; Wang, Z; Ye, J; Yin, C; Yu, G; Zhang, Y; Zhao, Q; Zhong, Q	1
Al-Ali, HK; Behre, G; Franke, GN; Hochhaus, A; Jentzsch, M; Klink, A; Niederwieser, D; Pfrepper, C; Sayer, HG; Schenk, T; Schwind, S	1
Cheah, CY; Chihara, D; Dabaja, BS; Fowler, NH; Gombos, DS; Milgrom, S; Pinnix, CC	1
Caballero, D; Canales, M; Dlouhy, I; González-Barca, E; López-Guillermo, A; Martín, A; Montes-Moreno, S; Ocio, EM; Redondo, AM; Salar, A	1
Afanasyev, B; Arcese, W; Bacigalupo, A; Beelen, D; Ciceri, F; Giebel, S; Gülbas, Z; Koc, Y; Labopin, M; Mohty, M; Nagler, A; Piemontese, S; Polge, E; Rubio, MT; Santarone, S; Savani, BN; Schmid, C; Tischer, J; Wu, D	1
Burger, E; Ferreri, AJ; Finke, J; Fricker, H; Fritsch, K; Grishina, O; Ihorst, G; Illerhaus, G; Kasenda, B; Mikesch, K; Schorb, E; Valk, E; Zucca, E	1
Chapuy, B; Feller, AC; Hasenclever, D; Hohloch, K; Loeffler, M; Pfreundschuh, M; Schmitz, N; Trümper, L; Wulf, G; Zeynalova, S; Ziepert, M	1
Benger, A; Berinstein, NL; Chen, BE; Couban, S; Crump, M; Davison, K; Desjardins, P; Djurfeldt, MS; Hay, AE; Kaizer, L; Kukreti, V; Mangel, J; Shepherd, LE; Zhu, L	1
Belhabri, A; Biron, P; Blay, JY; Chassagne-Clément, C; Ducray, F; Faurie, P; Ferlay, C; Fossard, G; Ghesquières, H; Jouanneau, E; Nicolas-Virelizier, E; Rey, P; Sebban, C; Sunyack, MP; Thiesse, P	1
Colgan, JP; Dalton, RJ; Geyer, SM; Inwards, DJ; Kurtin, PJ; LaPlant, BR; Micallef, IN; Michalak, JC; Moore, DF; Reeder, CB; Salim, M; Witzig, TE	1
Budning, A; Chan, HS; Dai, S; Dimaras, H; Doyle, J; Drake, J; Gallie, BL; Halliday, W; Héon, E	1
Chi, HS; Jang, S; Kang, YA; Kim, DY; Kim, SH; Lee, JH; Lee, KH; Lee, SS; Lee, YS; Lim, SN; Park, CJ; Ryu, SG; Seol, M; Yun, SC	1
Chamberlain, MC; Glantz, MJ; Johnston, SK; Van Horn, A	1
Cabanillas, F; Fayad, L; Hagemeister, F; Kantarjian, H; Kwak, LW; McLaughlin, P; Rodriguez, MA; Romaguera, J; Wang, M; Zhou, Y	1
Chamberlain, MC; Glantz, MJ	1
Altman, JK; Tallman, MS	1
Braverman, RS; Carlson, I; Liang, X; Petersen, WC; Schlis, KD; Wang, M	1
Baleydier, F; Bertrand, Y; Kebaili, K; Mialou, V; Pages, MP; Pondarre, C; Pracros, JP	1
Erwin, W; Evens, AM; Gordon, LI; Inwards, DJ; Mehta, J; Micallef, I; Molina, A; Patton, D; Rademaker, AW; Singhal, S; Spies, S; Tallman, MS; Weitner, BB; White, CA; Williams, SF; Winter, JN; Wiseman, G; Zimmer, M	1
Chang, H; He, C; Liu, T; Xiang, B; Xu, CG; Xu, J	1
André, N; Coze, C; Gentet, JC; Padovani, L; Rome, A; Verschuur, A	1
Czumbil, L; Gyánó, G; Iványi, JL; Marton, E; Plander, M; Tóth, C	1
Nagai, T	1
Almohamad, W; Brahimi, N; Delmas-Marsalet, B; Frénoy, N; Goldschmidt, E; Guettier, C; Gumus, Y; Haydar, M; Innominato, P; Machover, D; Misra, SC; Saffroy, R; Ulusakarya, A	1
Arceci, R; Dauses, T; Devetten, M; Gallagher, RE; Gojo, I; Gore, SD; Jamieson, K; Morris, L; Owoeye, I; Redner, RL; Schachter-Tokarz, E; Sekeres, MA	1
Cortes, J; Faderl, S; Freireich, E; Kantarjian, H; Keating, M; O'Brien, S; Pierce, S; Ravandi, F; Verma, D; Vu, K	1
Eskew, A; Grier, DD; McLean, TW; White, T	1
Andresen, S; Bolwell, B; Chan, J; Copelan, E; Dean, R; Kalaycio, M; Pohlman, B; Rybicki, L; Sobecks, R; Sproat, L; Sweetenham, J; Tench, S	1
Allen, S; Galinsky, I; Hurd, D; Kolitz, JE; Larson, RA; Marcucci, G; Moser, B; Sanford, B; Schulman, P; Stock, W; Stone, RM; Vij, R	1
Advani, A; Brady, AK; Copelan, E; Earl, M; Fu, AZ; Kalaycio, M; Saunthararajah, Y; Sekeres, MA; Sobecks, R	1
Cho, BS; Cho, SG; Choi, SM; Eom, KS; Kim, CC; Kim, HJ; Kim, YJ; Lee, DG; Lee, JW; Lee, S; Min, CK; Min, WS	1
Appelbaum, FR; Bennett, JM; Bloomfield, CD; de la Serna, J; Deben, G; Feusner, JH; Gallagher, R; Gonzalez, J; Gonzalez, M; Kim, HT; Larson, RA; Miguel, JD; Milone, G; Montesinos, P; Paietta, E; Rayon, C; Rivas, C; Rowe, JM; Sanz, MA; Schiffer, CA; Shepherd, L; Slack, JL; Tallman, MS; Vellenga, E; Wiernik, PH; Willman, CL	1
Bassan, R; Derigs, HG; Dombret, H; Gökbuget, N; Greil, R; Hartog, CM; Hernández-Rivas, JM; Hoelzer, D; Huguet, F; Intermesoli, T; Jourdan, E; Junghanss, C; Leimer, L; Moreno, MJ; Reichle, A; Ribera, J; Schmid, M; Serve, H; Stelljes, M; Stuhlmann, R	1
Handa, H; Hashimoto, K; Hashizume, M; Horiguchi, K; Kaneko, Y; Masuo, T; Mori, M; Nakazato, Y; Nojima, Y; Okada, S; Okajo, J; Sasaki, A; Suto, M; Tsukamoto, N; Yamada, M; Yokoo, H	1
Aurer, I; Baars, JW; Borchmann, P; DeJong, D; Diehl, V; Döhner, H; Engert, A; Fischer, T; Glossmann, J; Hansmann, ML; Josting, A; Metzner, B; Müller, H; Niederwieser, D; Raemaekers, J; Schäfer-Eckart, K; Schmitz, N; Smardova, L; Sureda, A	1
Teh, TC; Wei, A	1
Fernandez, HF; George, TJ; Ho, VQ; Kharfan-Dabaja, MA; Komrokji, RS; Lancet, JE; List, AF; Pinilla-Ibarz, J; Price, SL; Wetzstein, GA	1
Gill, D; Kennedy, G; Marlton, P; Mollee, P; Morris, K; Weston, H	1
Fukushima, T; Hanada, R; Hasegawa, D; Ishida, Y; Kikuchi, A; Kiyokawa, N; Koh, K; Manabe, A; Ohara, A; Saito, T; Tsuchida, M	1
Agura, E; Berryman, RB; Cooper, B; Fay, J; Holmes, H; Li, S; Maisel, C; Saracino, G; Tadic-Ovcina, M; Vance, E	1
Babyn, P; Chan, HS; Dimaras, H; Doyle, J; Gallie, BL; Halliday, W; Héon, E; Paton, KE; Strahlendorf, C	1
Alvaro, MG; Baraldi, A; Ciravegna, G; Corsetti, MT; De Paoli, L; Gatto, S; Levis, A; Perticone, S; Pietrasanta, D; Pini, M; Primon, V; Salvi, F; Tonso, A; Zallio, F	1
Hägglund, H; Karbach, H; Klimkowska, M; Machaczka, M; Nahi, H	1
Kuendgen, A	1
Choquet, S; del Rio, MS; Fourme, E; Glaisner, S; Hoang-Xuan, K; Janvier, M; Soussain, C	1
Batchelor, TT; Egerer, G; Engert, A; Herrlinger, U; Kowoll, A; Lamprecht, M; Linnebank, M; Patrij, K; Pels, H; Reiser, M; Schackert, G; Schlegel, U; Schmidt-Wolf, IG; Vogt-Schaden, M; Wätzel, L	1
Furuya, T; Ikeda, T; Inoue, M; Kaneda, H; Koshinaga, T; Maebayashi, T; Masuko, T; Mugishima, H; Ohashi, K; Sugito, K; Yagasaki, H	1
Abdelhamid, E; Berthon, C; Castaigne, S; Gardin, C; Gruson, B; Helevaut, N; Nibourel, O; Preudhomme, C; Renneville, A; Rousselot, P; Soua, Z	1
Kivivuori, SM; Nygaard, R	1
Ayari, S; Chevallier, P; Delaunay, J; Dumas, PY; Eveillard, M; Guillaume, T; Leguay, T; Lippert, E; Mohty, M; Pigneux, A; Robillard, N	1
Crump, M; Keating, A; Kuruvilla, J; Massey, C; Puig, N; Seshadri, T; Tsang, R; Villa, D	1
Abboud, CN; Cashen, AF; DiPersio, JF; Hladnik, LM; Kulkarni, S; McFarland, K; Motabi, IH; Rettig, MP; Stockerl-Goldstein, KE; Trinkaus, KM; Uy, GL; Vij, R; Westervelt, P	1
Barisone, E; Berger, M; Fagioli, F; Galletto, C; Manicone, R; Masetti, R; Pession, A; Quarello, P; Rivetti, E	1
Abbenante, MC; Astolfi, A; Baccarani, M; Candoni, A; Cattina, F; Damiani, D; Fanin, R; Ferrari, A; Formica, S; Gherlinzoni, F; Gottardi, M; Iacobucci, I; Lonetti, A; Malagola, M; Martinelli, G; Michelutti, A; Ottaviani, E; Papayannidis, C; Parisi, S; Russo, D; Sazzini, M; Simeone, E	1
Bowman, WP; Campana, D; Cao, X; Dahl, G; Inaba, H; Jenkins, L; Pounds, S; Pui, CH; Ribeiro, RC; Rubnitz, JE; Taub, JW	1
Colovic, M; Floros, KV; Gourgiotis, D; Pavlovic, S; Scorilas, A; Thomadaki, H; Tosic, N	1
Berdel, WE; Büchner, T; Döhner, H; Döhner, K; Ehninger, G; Ganser, A; Hasford, J; Hehlmann, R; Heil, G; Heinecke, A; Hiddemann, W; Hoelzer, D; Hoffmann, VS; Krahl, R; Kramer, M; Krauter, J; Krug, U; Niederwieser, DW; Pfirrmann, M; Sauerland, MC; Schaich, M; Schlenk, RF; Scholl, S; Späth, D	1
Anderson, D; Greaves, P; Gribben, JG; Lillington, D; Lister, TA; Matthews, J; Montoto, S	1
Anderson, H; Björkholm, M; Delabie, J; Eriksson, M; Erlanson, M; Fluge, O; Fosså, A; Holte, H; Janes, R; Jerkeman, M; Jyrkkiö, S; Karjalainen-Lindsberg, ML; Kolstad, A; Leppä, S; Löfvenberg, E; Nordström, M; Ostenstad, B; Pedersen, LM; Sundström, C	1
Adlard, K; Alonzo, TA; Cooper, TM; Gamis, AS; Gerbing, R; Perentesis, J; Raetz, E; Razzouk, BI; Whitlock, JA	1
Aliff, TB; Frankel, SR; Jurcic, JG; Kalaycio, ME; Maslak, PG; Roma, TE; Scheinberg, DA; Tallman, MS; Weiss, MA	1
Alvarez, R; Beran, M; Cortes, J; Estey, E; Giles, FJ; Kantarjian, H; Thomas, D; Tsimberidou, AM	1
Guang, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Liu, DG; Sun, XF; Xu, GC; Xu, RH; Zhang, L; Zhou, ZM	1
Jackson, AS; Lightman, S; Pavesio, C; Plowman, PN; Taylor, A	1
Benkirane, N; Berraho, A; Charif, CM; Loughzail, K	1
Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B	1
Davis, J; Estey, E; Kantarjian, H; Koller, C; O'Brien, S; Shen, Y; Thomas, MB; Yang, Y	1
Chen, J; Gu, L; Pan, C; Tang, J; Xue, H; Zhao, H	1
Fischer, DH; Mason, JO	1
Furukawa, H; Kinoshita, T; Kitamura, M; Kunii, Y; Motohashi, H; Nakajima, T; Nashimoto, A; Sasako, M; Yamamoto, S; Yamamura, Y	1
Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG	1
Dührsen, U; Dürig, J; Nückel, H	1
Chelghoum, Y; Elhamri, M; Le, QH; Michallet, M; Revesz, D; Thomas, X	1
Abrey, LE; Anderson, ND; Caron, D; Correa, DD; Crump, M; DeAngelis, LM; Forsyth, P; Mason, WP; Moskowitz, CH; Nimer, SD; Paleologos, N; Stewart, D; Zelenetz, A	1
Takeshita, A	1
Cunningham, MT; Davis, MK; Imkie, M; Persons, DL	1
Deckert, M; Montesinos-Rongen, M; Pels, H; Schaller, C; Schlegel, U; Van Roost, D; Wiestler, OD	1
Dutcher, JP; Karbasian-Esfahani, M; Novik, Y; Paietta, E; Wiernik, PH	1
Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM	1
Bayraktaroglu, T; Borazan, A; Demircan, N; Ozdemir, H; Ozer, T; Savranlar, A; Ustündag, Y	1
Ikeda, K; Matsumoto, K; Matsuoka, S; Ohta, M; Takeshita, I	1
Diehl, V; Dörken, B; Engert, A; Glossmann, JP; Josting, A; Kisro, J; Ko, Y; Mapara, M; Metzner, B; Nogova, L; Peters, N; Sieniawski, M; Staak, O	1
Da, WM; Li, HH; Wang, QS; Wang, SH; Wu, XX; Zhao, Y; Zhu, HY	1
Botton, Sd; Chelghoum, Y; Dhedin, N; Dombret, H; Dreyfus, F; Elhamri, M; Fenaux, P; Guerci, A; Le, Q; Michallet, M; Pautas, C; Pigneux, A; Raffoux, E; Reman, O; Revel, Td; Thiebaut, A; Thomas, X; Travade, P; Troncy, J; Vekhoff, A	1
Baars, J; Diehl, V; Engert, A; Haverkamp, H; Josting, A; Pfistner, B; Raemakers, J; Smardova, L	1
Kara, B; Kara, IO; Paydas, S; Sahin, B	1
Bao, L; Huang, XJ; Jiang, B; Lu, DP; Lu, J; Lu, XJ; Qiu, JY; Shi, HX; Wang, DB; Wang, FR	1
Bauer, KS; Bible, K; Briel, J; Colevas, AD; Garimella, TS; Gojo, I; Gore, SD; Greer, J; Karp, JE; Kaufmann, S; Passaniti, A; Ross, DD; Smith, BD; Tidwell, ML; Wright, JJ	1
Auvrignon, A; Baruchel, A; Brethon, B; Cayuela, JM; Lapillonne, H; Leverger, G	1
Bello, JL; Bethencourt, C; Deben, G; Feliu, E; Hernandez-Rivas, JM; Oriol, A; Parody, R; Ribera, JM; Rivas, C; Sancho, JM	1
Gisselbrecht, C; Hagberg, H	1
Benedetti, F; Boccadoro, M; Boccomini, C; Callea, V; Corradini, P; Coser, P; De Marco, F; Ladetto, M; Martelli, M; Patti, C; Perrotti, A; Pulsoni, A; Rosato, R; Scimè, R; Sorio, M; Stelitano, C; Tarella, C; Vallet, S; Vitolo, U; Zanni, M	1
Birkmann, J; Bopp, C; Flieger, D; Florschütz, A; Glasmacher, AG; Gorschlüter, M; Hahn, C; Hensel, M; Ho, AD; Kaiser, U; Mey, UJ; Neubauer, A; Orlopp, KS; Rabe, C; Schmidt-Wolf, IG; Strehl, JW; Wilhelm, M	1
Fangusaro, J; Finlay, J; Rook, J; Rosser, T	1
Huh, J; Jeong, YP; Kim, S; Kim, SB; Kim, SW; Ko, OB; Koo, JE; Lee, D; Lee, JL; Park, SH; Suh, C	1
Bories, D; Cordonnier, C; Itti, E; Karlin, L; Maury, S; Pautas, C; Rachid, M	1
Aydin, S; Dührsen, U; Nückel, H	1
Atta, J; Chow, KU; Hoelzer, D; Martin, H; Mitrou, PS; Weidmann, E	1
Allievi, C; Bernareggi, A; Cabanillas, F; Fayad, L; Laffranchi, B; Levine, AM; Lim, ST; Modiano, M; Tulpule, A	1
Benaroush, M; Blumenfeld, Z; Zuckerman, T	1
Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM	1
Brocca, MC; Coppi, MR; Mele, G; Melpignano, A; Pinna, S; Quarta, G; Romano, A	1
Guan, ZZ; Huang, HQ; Li, YH; Ling, JY; Liu, DG; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM	1
Albarello, A; Bacigalupo, A; Balleari, E; Balocco, M; Carella, AM; Catania, G; Clavio, M; Gobbi, M; Manna, A; Michelis, G; Miglino, M; Pierri, I; Sessarego, M; Van Lint, MT; Varaldo, R; Vignolo, L	1
Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P	1
Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H	1
Briel, J; Colevas, AD; Gore, SD; Greer, J; Hattenburg, C; Jones, RJ; Karp, JE; Levis, MJ; Smith, BD; Wright, JJ	1
Al-Ali, HK; Niederwieser, D; Wittekind, C	1
Falk, P; Forman, SJ; Fung, HC; Krishnan, A; Molina, A; Nademanee, A; Palmer, JM; Raubitschek, AA; Rodriguez, R; Spielberger, RT; Yamauchi, D	1
Caballero, D; Canals, C; Finke, J; Goldstone, A; Hunter, A; Kienast, J; Kobbe, G; Kolb, HJ; Kyriakou, C; Metzner, B; Oberg, G; Reimer, P; Schmitz, N; Sureda, A; Theorin, N	1
Amrein, PC; Attar, EC; Ballen, KK; D'Amato, F; De Angelo, DJ; Galinsky, I; Levine, J; McAfee, S; Miller, KB; Neuberg, D; Schenkein, D; Sirulnik, A; Stone, RM; Supko, JG; Trehu, EG; Wadleigh, M; Zahrieh, D	1
Rowe, JM	1
Casasnovas, O; Choquet, S; Dupriez, B; Fourme, E; Gisselbrecht, C; Hoang-Xuan, K; Jaccard, A; Janvier, M; Kolb, B; Leblond, V; Omuro, A; Sanson, M; Souleau, B; Soussain, C; Taillandier, L; Taksin, AL; Witz, F; Zini, JM	1
Hong, M; Li, JY; Lu, H; Lu, SF; Shen, WY; Wang, LX; Yang, H; Zhang, JF	1
Aitkens, S; Belanger, G; Benoit, B; Dennery, J; Grahovac, Z; Hugenholtz, H; Peterson, E; Richard, MT; Russell, N; Stewart, DJ	1
Ikeuchi, T; Kai, Y; Onodera, Y	1
Fujioka, H; Matsuda, M; Matsumiya, K; Nakano, E; Osafune, M; Sonoda, T; Tada, Y; Takaha, M	1
Alic, L; Haid, M	1
Kovats, E; Lehmann, HG; Micksche, M; Rainer, H; Rauhs, R; Schemper, M; Schiessel, R; Schweiger, B; Sedlacek, HH; Seidl, W; Wunderlich, M	1
Ariyoshi, A; Ishisawa, N; Kano, M; Masaki, Z; Momose, S; Morita, I; Omoto, T	1
Averette, HE; Jobson, VW; Nordqvist, SR	1
Arlin, ZA; Clarkson, BD; Dellaquila, C; Flomenberg, N; Gee, TS; Kempin, SJ; Mertelsmann, R; Straus, DJ; Young, CW	1
Edwards, MS; Fulton, DS; Gutin, PH; Levin, VA; Seager, ML; Stewart, J; Wilson, CB	1
Jarowski, CI; Saper, CB	1
Bagshawe, KD; Begent, RH; Brampton, M; Holden, L; Ledermann, JA; Newlands, ES; Rustin, GJ	1
Feldmann, L; Guerci, A; Guerci, O; Marchal, S; Merlin, JL; Missoum, N; Rose, C; Witz, F	1
Bergmann, L; Hoelzer, D; Jacobi, V; Lob, S; Müller, H	1
Anderson, JR; Cecalupo, AJ; Finlay, JL; Hutchinson, RJ; Kadin, ME; Kjeldsberg, CR; Meadows, AT; Provisor, AJ; Woods, WG	1
Inoue, T; Ishii, E; Koga, H; Matsuzaki, A; Miyake, K; Miyazaki, S; Nibu, K; Take, H; Ueda, K; Yanai, F	1
Cabanillas, F; Rodriguez, MA	1
Dreger, P; Gassmann, W; Glass, B; Haferlach, T; Horst, HA; Löffler, H; Ollech-Chwoyka, J; Schmitz, N; Suttorp, M	1
Fujisawa, M; Hashimoto, H; Niibori, D; Ohashi, K; Osanai, H; Wakabayashi, A; Watabe, Y; Yachiku, S; Yamauchi, K	1
Argüello, A; Barrantes, JC; Barrantes, M; García, I; Jiménez, R; Lobo-Sanahuja, F	1
Lightman, S; Montefiore, DS; Plowman, PN	1
Albain, KS; Crowley, JJ; Gandara, D; Griffin, B; Hutchins, L; Livingston, RB; O'Bryan, RM; Von Hoff, DD	1
Smith, PJ; Stevens, M; Tiedemann, K; Toogood, IR	1
Johnson, PW; Lister, TA; McCallum, P; Norton, AJ; Rohatiner, AZ; Sweetenham, JW	1
Bastit, D; Boulet, D; Fruchart, C; Moncondult, M; Piguet, H; Stamatoullas, A; Tilly, H	1
Döhner, H; Flentje, M; Goldschmidt, H; Haas, R; Hunstein, W; Möhle, R; Moos, M; Murea, S; Wannenmacher, M; Witt, B	1
Chiusolo, P; Di Mario, A; Leone, G; Micciulli, G; Salutari, P; Sica, S; Tommasi, M	1
Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M	1
Kearns, P; Majumdar, G; Partridge, F; Richardson, W; Wilcox, R	1
Chamberlain, MC	1
Gau, JP; Ho, KC; Lin, TH; Yang, Y; Young, JH	1
Adle-Biassette, H; Authier, FJ; Chomienne, C; Defer, GL; Degos, JD; Degos, L; Martin, L; Ricolfi, F	1
Akashi, K; Eto, T; Fujisaki, T; Gondo, H; Harada, M; Harada, N; Hayashi, S; Hirota, Y; Kinukawa, N; Makino, S; Matsuishi, E; Miyamoto, T; Mizuno, S; Murakawa, M; Nagafuji, K; Niho, Y; Ohno, Y; Okamura, T; Shibuya, T; Takamatsu, Y; Takenaka, K; Taniguchi, S; Tanimoto, K; Teshima, T; Yamasaki, K	1
Clemens, M; Dichgans, J; Herrlinger, U; Kortmann, RD; Meyermann, R; Petersen, D; Schabet, M; Will, BE	1
Diehl, V; Engert, A; Josting, A; Kàtay, I; Rueffer, U; Tesch, H; Wickramanayake, PD; Winter, S	1
Carrera, I; Ding, W; Gallagher, RE; Grills, G; Li, YP; Nobile, LM; Paietta, E; Tallman, MS; Wiernik, PH	1
Arakawa, M; Chou, T; Emura, I; Ishiguro, T; Kakihara, T; Naito, M; Yoshizawa, H	1
Biondi, A; Coppi, MR; Liso, V; Mestice, A; Mininni, D; Palumbo, G; Pogliani, EM; Rossi, V; Specchia, G; Teruzzi, E	1
Chan, CC; de Smet, MD; Kohler, D; Solomon, D; Vancs, VS	1
Iwata, N; Kawahigashi, N; Kobayashi, Y; Maeda, A; Saito, T; Takaue, Y; Takenaka, T; Tanosaki, R; Tobinai, K; Togitani, K	1
Diehl, V; Draube, A; Engert, A; Josting, A; Reiser, M; Rueffer, U; Söhngen, D; Tesch, H; Wickramanayake, PD; Wolf, J	1
Armata, J; Balcerska, A; Balwierz, W; Bogusławska-Jaworska, J; Bubała, H; Chybicka, A; Filiks-Litwin, B; Gorczyńska, E; Juszczak, K; Kowalczyk, J; Kołecki, P; Lukowska, K; Matysiak, M; Rokicka-Milewska, R; Rola-Kurc, E; Sońta-Jakimczyk, D; Stencel, D; Strojny, W; Wachowiak, J; Wieczorek, M; Wysocki, M; Zelenay, E	1
Belasco, JB; Bunin, NJ; Lange, BJ; Leahey, AM; Meek, R; Scher, C	1
Gangadharan, VP; Jayasree, K; Nayak, N; Prakash, NP	1
Aird, W; Amrein, P; MacNeill, K; Neuberg, D; Shulman, LN; Sternberg, DW; Thompson, L	1
Berglund, A; Carlson, K; Enblad, G; Glimelius, B; Hagberg, H	1
Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M	1
Bergmann, L; Blaise, D; Bosi, A; Cahn, JY; Cornelissen, J; De Witte, T; Ferrant, A; Frassoni, F; Gorin, NC; Labopin, M; Reiffers, J; Sierra, J; Visani, G	1
Deininger, MH; Grote, E; Meyermann, R; Wickboldt, J	1
Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F	1
Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Ferrer Albiach, C; Pallardó-Calatayud, J; Romero-de-Avila, C; Ruiz Hernández, G	1
Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G	1
Birkmann, J; Ehninger, G; Fiedler, F; Friedrichsen, K; Hänel, A; Hänel, M; Herbst, R; Kröger, N; Kroschinsky, F; Naumann, R; Zander, AR	1
DeAngelis, LM; Gijtenbeek, JM; Rosenblum, MK	1
Dreger, P; Glass, B; Kuse, R; Schmitz, N; Seyfarth, B; Sonnen, R	1
Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J	1
Bertè, R; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Vallisa, D	1
Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K	1
Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B	1
Becherer, A; Dudczak, R; Greinix, HT; Jaeger, U; Kalhs, P; Karanikas, G; Kletter, K; Mitterbauer, M; Pötzi, C; Raderer, M	1
Arnulf, B; Belanger, C; Bouabdallah, R; Brousse, N; Casasnovas, RO; Damaj, G; Delabesse, E; Delmer, A; Djabarri, M; Dreyfus, F; Hermine, O; Janvier, M; Lefrère, F; Levy, V; Maillard, N; McIntyre, E; Ribrag, V; Sebban, C; Suzan, F; Valensi, F; Varet, B; Verkarre, V	1
Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Linfomi, MB; Luminari, S; Santini, G	1
DiSaia, PJ; Forney, JP; Futoran, RJ; Morrow, CP	1
Gale, RP	1
Mutz, ID	1
Damiani, D; Dinota, A; Fanin, R; Geromin, A; Michelutti, A; Michieli, M; Pileri, S; Raspadori, D; Russo, D; Visani, G	1
Fujieda, J; Kawakura, K; Koyanagi, T; Maru, A; Nishida, T; Ohashi, N; Shinohara, N; Togashi, M; Toyota, K	1
Haake, R; Kersey, JH; Ramsay, NK; Uckun, FM; Weisdorf, D	1
Schaison, GS	1
Capalbo, S; Dione, R; Iacobazzi, A; Iaculli, ML; Liso, V; Pansini, N; Pavone, V; Specchia, G	1
Hironaka, T; Horiike, S; Kashima, K; Misawa, S; Nakagawa, H; Nishigaki, H; Shizumi, Y; Takashima, T; Tanaka, S; Taniwaki, M	1
De Fabritiis, P; Mandelli, F; Meloni, G; Petti, MC; Pinto, MR; Testi, AM; Vegna, ML; Vignetti, M	1
Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S	1
Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD	1
Björkholm, M; Ideström, K; Johansson, B; Kimby, E; Lindemalm, C; Merk, K; Osby, E	1
Almadrones, L; Eriksson, J; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S; Yordan, EL	1
Appelbaum, F; Collins, C; Livingston, R; Mortimer, J; Press, OW	1
Archimbaud, E; Cordonnier, C; Devaux, Y; Dreyfus, F; Fenaux, P; Fiere, D; Jaubert, J; Leblond, V; Michallet, M; Travade, P	1
Beck, D; de Crousaz, H; Deonna, T; Janzer, RC; Miklossy, J; von der Weid, NX	1
Miura, K; Tsukada, T; Yuri, Y	1
Asakawa, M; Iseki, T; Kishimoto, T; Maekawa, M; Nakatani, T; Nishio, S; Sakamoto, W; Wada, S; Yasumoto, R; Yoshihara, H	1
De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P	1
Aul, HC; Donhuijsen-Ant, R; Grüneisen, T; Hiddemann, W; Köppler, H; Lathan, B; Ludwig, WD; Maschmeyer, G; Reichle, A; Urbanitz, D	1
Buscarini, L; Cavanna, L; Civardi, G; Di Stasi, M; Fornari, F; Moretto, M; Sbolli, G	1
Dahl, GV; Johnson, FL; Kalwinsky, DK; Look, AT; Mason, C; Mirro, J; Murphy, SB; Pui, CH; Ruggiero, M; Schell, M	1
Békássy, AN; Garwicz, S; Gulliksson, H; Liliemark, J; Peterson, C; Wiebe, T	1
Broustet, A; Cony, P; Duclos, F; Marit, G; Puntous, M; Reiffers, J	1
Evans, C; Rosenfeld, CS; Shadduck, RK; Winkelstein, A; Zeigler, ZR	1
Anderson, T; Baumann, MA; Hande, KR; Ritch, PS; Topping, TM; Williams, GA	1
Athanassiou, A; Bafaloukos, D; Barbounis, V; Christodoulou, K; Dimitriadis, M; Pectasides, D	1
Caligiuri, MA; Canellos, GP; Soiffer, RJ; Tondini, C	1
Kanai, M; Kanno, M; Kobayashi, K; Kondo, K; Matano, S; Matsuda, T; Nakamura, S; Ohtake, S; Okafuji, K; Yoshida, T	1
Brinch, L; Evensen, SA; Wisløff, F	1
Callís, M; Domingo Albós, A; Fernández-Sevilla, A; Juliá, A; Petit, J; Puig, J; Vilá, J; Zuazu, J	1
Alexanian, R; Barlogie, B; Cabanillas, F; Velasquez, WS	1
Hara, J; Ishihara, S; Izumi, Y; Kozaiwa, K; Matsumoto, Y; Murata, M; Nishida, M; Sato, A; Tawa, A; Yumura-Yagi, K	1
Akman, S; Carr, B; Doroshow, J; Leong, L; Margolin, K	1
Gray, RG; Hayhoe, FG; Rees, JK; Swirsky, D	1
Berry, D; Crist, W; Doering, E; Fernbach, D; Pullen, J; Shuster, J; van Eys, J; Wharam, M	1
Onundarson, PT; Rowe, JM	1
Bordigoni, P; Cornu, G; Grosbois, B; Lederlin, P; Olive, D; Schaison, G; Troussard, X; Witz, F	1
Bleyer, WA; Geyer, JR; Heideman, RL; Kosnik, EJ; Milstein, JM; Morris, JD; Mulne, AF; Pendergrass, TW; Ruymann, FB; Stuntz, JT	1
Arnet, B; Baumgartner, C; Beck, D; Berchtold, W; Bertrand, AM; Bleher, EA; Caflisch, U; Delaleu, B; Feldges, A; Stucki, F	1
Capizzi, RL; Cooper, MR; Craig, JB; Hampton, JW; Muss, HB; Powell, BL; Schnell, FM; Smith, LR; White, DR; Zekan, PJ	1
Ochocka, M; Zelenay, E	1
Iwase, Y; Sakagami, H; Tsugaya, M; Washida, H	1
Appelbaum, FR; Buckner, CD	1
Baumgarten, E; Buchmann, S; Fengler, R; Grosch-Wörner, I; Henze, G; Schulte-Overberg, U	1
Capizzi, RL; Powell, BL	1
Colly, LP; Peters, WG; Willemze, R	1
Doi, S; Hara, J; Ishihara, S; Izumi, Y; Kawa, K; Murata, M; Sato, A; Tawa, A; Yabuuchi, H; Yumura, K	1
Borrego, D; Jarque, I; Lorenzo, I; Martín-Aragonés, G; Martínez, JA; Pastor, E; Rafecas, J; Sanz, G; Sanz, MA; Sayas, MJ	1
Olson, EZ; Selders, NJ	1
Amino, I; Fujieda, J; Koyanagi, T; Kusakai, Y; Maru, A; Nantani, M; Nishida, T; Ohashi, N; Omuro, H; Yamada, T	1
Ausserer, B; Bettelheim, P; Gadner, H; Grienberger, H; Grümayer, ER; Haas, OA; Krepler, P; Kummer, M; Pawlovsky, J; Schmidmeier, W	1
Atkinson, EN; Drewinko, B; Freedman, RS; Keeney, ED; Rutledge, FN	1
Simmonds, WP	1
Bluming, AZ; Fass, L; Iversen, OH; Morrow, RH; Ziegler, JL	1
Clifford, P; Demissie, A; Guerra, A; Gunvén, P; Henle, G; Henle, W; Hewetson, JF; Klein, G; Rocchi, G; Singh, S; Svedmyr, A	1
Clarkson, BD; Fried, J; Sheehy, PF; Winn, R	1
Kuretani, K; Nakahara, W; Tokuzen, R	1
Carbone, PP; Fass, L; Kyalwazi, SK; Morrow, RH; Ziegler, JL	1

Reviews

11 review(s) available for cytarabine and Local Neoplasm Recurrence

Article	Year
Quantitative evaluation of therapy options for relapsed/refractory diffuse large B-cell lymphoma: A model-based meta-analysis. Pharmacological research, 2023, Volume: 187 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Rituximab; Transplantation, Autologous	2023
Procarbazine, lomustine and vincristine for recurrent high-grade glioma. The Cochrane database of systematic reviews, 2017, 07-26, Volume: 7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Glioma; Humans; Hydroxyurea; Lomustine; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Randomized Controlled Trials as Topic; Temozolomide; Vincristine	2017
A Bayesian Network Meta-Analysis Comparing the Efficacies of Eleven Novel Therapies with the Common Salvage Regimen for Relapsed or Refractory Acute Myeloid Leukemia. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 49, Issue:4 Topics: Bayes Theorem; Cytarabine; Disease-Free Survival; Histone Deacetylase Inhibitors; Humans; Leukemia, Myeloid, Acute; Naphthyridines; Neoplasm Recurrence, Local; Odds Ratio; Pyrazoles; Pyrimidines; Remission Induction; Salvage Therapy; Survival Rate; Thiazoles	2018
[Treatment strategy of Hodgkin lymphoma]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Mechlorethamine; Melphalan; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Rituximab; Vinblastine; Vincristine	2014
[Combination chemotherapy for acute myeloid leukemia]. Nihon rinsho. Japanese journal of clinical medicine, 2009, Volume: 67, Issue:10 Topics: Aged; Aged, 80 and over; Aminoglycosides; Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy	2009
[Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:12 Topics: Alkyl and Aryl Transferases; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Cyclosporine; Cytarabine; Daunorubicin; Drug Design; Farnesyltranstransferase; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Nucleosides; Oxides; Prognosis; Radioisotopes; Remission Induction; Tetrahydronaphthalenes; Topoisomerase Inhibitors; Tretinoin; Verapamil	2003
Consolidation therapy: what should be the standard of care? Best practice & research. Clinical haematology, 2008, Volume: 21, Issue:1 Topics: Adolescent; Adult; Age Factors; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cytarabine; Disease-Free Survival; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Remission Induction	2008
[Role of bone marrow graft in the treatment of acute lymphoblastic leukemias in children]. Presse medicale (Paris, France : 1983), 1992, Apr-18, Volume: 21, Issue:15 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Female; Graft vs Host Reaction; HLA Antigens; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous; Transplantation, Homologous	1992
Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma. International journal of hematology, 1991, Volume: 54, Issue:3 Topics: Aclarubicin; Adolescent; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Carcinoma, Hepatocellular; Child; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 5; Cytarabine; Daunorubicin; Doxorubicin; Female; Hepatectomy; Hepatitis B; Humans; Leukemia, Erythroblastic, Acute; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisolone; Remission Induction; Translocation, Genetic	1991
Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia. Medical and pediatric oncology, 1991, Volume: 19, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Coma; Cytarabine; Female; Humans; Injections, Spinal; Methotrexate; Neoplasm Recurrence, Local; Paralysis; Paraplegia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Spinal Cord Diseases	1991
Overview of the clinical relevance of autologous bone marrow transplantation. Clinics in haematology, 1986, Volume: 15, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous	1986

Trials

121 trial(s) available for cytarabine and Local Neoplasm Recurrence

Article	Year
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA. Proteomics. Clinical applications, 2022, Volume: 16, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Child; Cytarabine; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; NF-kappa B; Phosphorylation; Transcription Factor RelA	2022
Treatment intensification with FLAG-Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long-term follow up of the MRC AML15 trial. British journal of haematology, 2022, Volume: 196, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Remission Induction; Vidarabine	2022
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma. Transplantation and cellular therapy, 2022, Volume: 28, Issue:8 Topics: Bendamustine Hydrochloride; Cytarabine; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Multiple Myeloma; Neoplasm Recurrence, Local; Transplantation, Autologous	2022
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortium. Pediatric blood & cancer, 2022, Volume: 69, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Decitabine; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Vidarabine; Vorinostat	2022
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A British journal of haematology, 2023, Volume: 200, Issue:2 Topics: Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cytarabine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning	2023
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided BMC cancer, 2022, Nov-14, Volume: 22, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Clinical Trials, Phase II as Topic; Cytarabine; Humans; Leukemia, Myeloid, Acute; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Nuclear Proteins; Quality of Life; Standard of Care	2022
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms. Leukemia & lymphoma, 2023, Volume: 64, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Neoplasm Recurrence, Local	2023
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial. The Lancet. Haematology, 2023, Volume: 10, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Nuclear Proteins; Treatment Outcome; Tretinoin; Young Adult	2023
Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma. British journal of haematology, 2023, Volume: 202, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cytarabine; Dexamethasone; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local; Treatment Outcome	2023
Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study. International journal of hematology, 2020, Volume: 111, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Feasibility Studies; Humans; Lymphoma, AIDS-Related; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Safety; Survival Rate; Transplantation, Autologous	2020
Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma. Hematological oncology, 2020, Volume: 38, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Central Nervous System Neoplasms; Cytarabine; Disease Progression; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Retrospective Studies; Risk Assessment; Survival Rate	2020
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study. Haematologica, 2021, 04-01, Volume: 106, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cisplatin; Cytarabine; Dexamethasone; Hodgkin Disease; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Recurrence; Salvage Therapy; Treatment Outcome	2021
Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience. Pediatric blood & cancer, 2020, Volume: 67, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Vidarabine	2020
Impact of contemporary regimens on the outcomes and toxicity of primary CNS lymphoma: a single-center retrospective analysis of 73 patients. Journal of neuro-oncology, 2021, Volume: 151, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Survival Rate; Venous Thromboembolism	2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients. Annals of hematology, 2021, Volume: 100, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Granulocyte Colony-Stimulating Factor; Humans; Hydrazines; Idarubicin; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Triazoles; Vidarabine	2021
Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma. Blood cancer journal, 2021, 05-17, Volume: 11, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lenalidomide; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Survival Analysis	2021
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 09-01, Volume: 39, Issue:25 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sulfonamides; Survival Rate; Vidarabine; Young Adult	2021
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years. Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy	2022
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Co Pediatric blood & cancer, 2017, Volume: 64, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Child; Child, Preschool; Cyclams; Cytarabine; Etoposide; Female; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, CXCR4; Treatment Outcome; Young Adult	2017
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia. Leukemia & lymphoma, 2018, Volume: 59, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clofarabine; Cytarabine; Drug Resistance, Neoplasm; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Remission Induction; Survival Rate; Treatment Outcome; Vidarabine; Young Adult	2018
Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse. The Journal of clinical investigation, 2017, Sep-01, Volume: 127, Issue:9 Topics: Adult; Aged; Alleles; Anthracyclines; Bone Marrow; Cytarabine; Exome; Female; Hematopoiesis; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm, Residual; Phenotype; Prognosis; Remission Induction; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Treatment Outcome; Young Adult	2017
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia. Leukemia research, 2017, Volume: 61 Topics: Adult; Aged; Antineoplastic Agents; Checkpoint Kinase 1; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrazoles; Pyrimidines	2017
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia. Clinical lymphoma, myeloma & leukemia, 2017, Volume: 17, Issue:12 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Edema; Female; Granulocyte Colony-Stimulating Factor; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome	2017
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study. Oncology, 2018, Volume: 94, Issue:5 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction	2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma. Cancer, 2018, 06-15, Volume: 124, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Rituximab; Survival Rate; Time Factors; Treatment Failure; Vincristine	2018
Mogamulizumab Haematologica, 2019, Volume: 104, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Humans; International Agencies; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Oxaliplatin; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Young Adult	2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group). Annals of oncology : official journal of the European Society for Medical Oncology, 2019, 04-01, Volume: 30, Issue:4 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prednisone; Progression-Free Survival; Salvage Therapy; Transplantation, Autologous; Young Adult	2019
Phase 1-2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia. British journal of haematology, 2019, Volume: 186, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Decitabine; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Treatment Outcome	2019
A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 07-15, Volume: 25, Issue:14 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Glycine; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Patient Safety; Remission Induction; Salvage Therapy; Treatment Outcome	2019
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia. Blood, 2013, Apr-18, Volume: 121, Issue:16 Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cytarabine; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Oxides; Remission Induction; Transcription, Genetic; Transplantation, Autologous; Young Adult	2013
A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large ce BMC cancer, 2013, Jun-25, Volume: 13 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Feasibility Studies; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Research Design; Rituximab; Salvage Therapy; Sirolimus; TOR Serine-Threonine Kinases	2013
Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia. Leukemia & lymphoma, 2014, Volume: 55, Issue:6 Topics: Aged; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodeoxyribonucleotides	2014
Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts. Cancer science, 2014, Volume: 105, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CD56 Antigen; Cytarabine; Disease-Free Survival; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Count; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Tretinoin; Young Adult	2014
A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Pediatric blood & cancer, 2014, Volume: 61, Issue:10 Topics: Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Pyrazines; Rabbits; Salvage Therapy; Treatment Outcome; Young Adult	2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia. Haematologica, 2015, Volume: 100, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Naphthyridines; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Salvage Therapy; Survival Rate; Thiazoles; Young Adult	2015
A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E. Haematologica, 2015, Volume: 100, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Drug Resistance, Neoplasm; Eukaryotic Initiation Factor-4E; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Ribavirin; Salvage Therapy; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult	2015
Re-induction with L-DNR/FLAG improves response after AML relapse, but not long-term survival. Klinische Padiatrie, 2014, Volume: 226, Issue:6-7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Doxorubicin; Female; Follow-Up Studies; Germany; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Polyethylene Glycols; Remission Induction; Retreatment; Selection Bias; Survival Rate; Vidarabine; Young Adult	2014
Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia. Leukemia, 2015, Volume: 29, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cohort Studies; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gene Expression Profiling; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Young Adult	2015
Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia. Blood, 2015, May-07, Volume: 125, Issue:19 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthyridines; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Thiazoles	2015
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL). Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Routes; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Vidarabine; Young Adult	2015
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study. The Lancet. Oncology, 2015, Volume: 16, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthyridines; Neoplasm Recurrence, Local; Remission Induction; Thiazoles; Treatment Outcome	2015
Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro-oncology, 2016, Volume: 18, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Follow-Up Studies; Humans; Immunotherapy; Intraocular Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Procarbazine; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Vincristine	2016
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group. British journal of haematology, 2016, Volume: 173, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Treatment Outcome; Young Adult	2016
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix). BMC cancer, 2016, Apr-21, Volume: 16 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Stem Cell Transplantation; Thiotepa; Transplantation, Autologous	2016
Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma. Annals of hematology, 2016, Volume: 95, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prospective Studies; Salvage Therapy; Transplantation, Autologous; Young Adult	2016
Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 03-01, Volume: 28, Issue:3 Topics: Adult; Age Factors; Aged; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome	2017
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group. Leukemia & lymphoma, 2008, Volume: 49, Issue:6 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Rituximab; Salvage Therapy; Treatment Outcome	2008
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia. Leukemia research, 2009, Volume: 33, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Treatment Outcome	2009
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C. Journal of neuro-oncology, 2009, Volume: 91, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Cytarabine; Drug Administration Routes; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Meningitis; Middle Aged; Neoplasm Recurrence, Local; Phospholipids; Rituximab; Survival Analysis	2009
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma. Cancer, 2008, Nov-15, Volume: 113, Issue:10 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Rituximab; Salvage Therapy; Vincristine	2008
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Apr-01, Volume: 27, Issue:10 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Female; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell; Male; Maximum Tolerated Dose; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Radioimmunotherapy; Radiotherapy Dosage; Salvage Therapy; Transplantation, Autologous	2009
[A clinical trial for homoharringtonine and low-dose cytosine arabinoside combined with G-CSF or GM-CSF to treat the relapsed or refractory acute myeloid leukemia (AML), geriatric AML and advanced myelodysplastic syndromes]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2009, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Harringtonines; Homoharringtonine; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Young Adult	2009
Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Peripheral Nervous System Diseases; Rituximab; Treatment Outcome	2010
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-20, Volume: 28, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxides; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin; Young Adult	2010
High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902. Leukemia research, 2011, Volume: 35, Issue:3 Topics: Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cohort Studies; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemtuzumab; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome	2011
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group. Blood, 2010, Dec-16, Volume: 116, Issue:25 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin; Young Adult	2010
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma. Haematologica, 2011, Volume: 96, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Central Nervous System Neoplasms; Cytarabine; Female; Humans; International Agencies; Liposomes; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Young Adult	2011
Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Dec-01, Volume: 28, Issue:34 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Methotrexate; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prognosis	2010
The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study. Pediatric blood & cancer, 2012, Volume: 58, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Central Nervous System Neoplasms; Child; Child, Preschool; Cohort Studies; Cytarabine; Female; Humans; Infant; Injections, Spinal; Male; Methotrexate; Neoplasm Recurrence, Local; Netherlands; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Remission Induction; Spinal Puncture; Survival Rate; Time Factors; Treatment Outcome	2012
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity. The oncologist, 2011, Volume: 16, Issue:2 Topics: Adenine Nucleotides; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome	2011
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C. Leukemia research, 2011, Volume: 35, Issue:8 Topics: Aged; Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Anticonvulsants; Antimetabolites, Antineoplastic; Cytarabine; Drug Therapy, Combination; Feasibility Studies; Female; Follow-Up Studies; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Valproic Acid	2011
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood, 2012, Apr-26, Volume: 119, Issue:17 Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Cyclams; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Receptors, CXCR4; Remission Induction; Salvage Therapy; Survival Rate; Young Adult	2012
Treatment outcome in older patients with childhood acute myeloid leukemia. Cancer, 2012, Dec-15, Volume: 118, Issue:24 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Transplantation, Autologous; Young Adult	2012
Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Oct-10, Volume: 30, Issue:29 Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germany; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Survival Analysis; Treatment Outcome; Young Adult	2012
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:5 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine; Young Adult	2013
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group. Pediatric blood & cancer, 2013, Volume: 60, Issue:7 Topics: Adenine Nucleotides; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Young Adult	2013
A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia. Cancer, 2002, Aug-01, Volume: 95, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cognition; Conjunctivitis; Cytarabine; Dose-Response Relationship, Drug; Female; Fever; Heart; Hematemesis; Humans; Idarubicin; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Treatment Outcome	2002
Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia. Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:6 Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Gemtuzumab; Humans; Infusions, Intravenous; Leukemia, Myeloid; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Remission Induction; Salvage Therapy; Sialic Acid Binding Ig-like Lectin 3; Survival Rate; Topotecan; Treatment Outcome	2002
[Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma]. Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cytarabine; Dexamethasone; Female; Fever; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; Vomiting	2002
A homoharringtonine-based regimen for childhood acute myelogenous leukemia. Medical and pediatric oncology, 2003, Volume: 41, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; China; Cytarabine; Disease-Free Survival; Etoposide; Female; Harringtonines; Homoharringtonine; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome	2003
Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jun-15, Volume: 21, Issue:12 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Fluorouracil; Gastrectomy; Humans; Infusions, Intravenous; Japan; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Stomach Neoplasms; Survival Rate; Treatment Outcome	2003
Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Annals of hematology, 2003, Volume: 82, Issue:11 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Salvage Therapy; Survival Rate	2003
Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia. Cancer, 2004, Sep-15, Volume: 101, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Idarubicin; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Thrombocytopenia	2004
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome	2005
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Dec-01, Volume: 11, Issue:23 Topics: Adult; Aged; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cattle; Cell Proliferation; Cohort Studies; Cytarabine; Endothelium, Vascular; Female; Flavonoids; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Piperidines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; U937 Cells; Vascular Endothelial Growth Factor A	2005
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17 Suppl 4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome	2006
Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial. Leukemia, 2006, Volume: 20, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphoma, Follicular; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine; Whole-Body Irradiation	2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. Cancer investigation, 2006, Volume: 24, Issue:6 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome	2006
ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience. The Korean journal of internal medicine, 2006, Volume: 21, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease Progression; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Analysis; Treatment Failure	2006
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients. Annals of hematology, 2007, Volume: 86, Issue:4 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome	2007
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma, 2007, Volume: 48, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Isoquinolines; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Salvage Therapy; Treatment Outcome	2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asian People; Asparaginase; Child; Child, Preschool; China; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Treatment Outcome; Vincristine	2007
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison British journal of haematology, 2007, Volume: 138, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Female; Gemtuzumab; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Prospective Studies; Survival Analysis; Treatment Outcome; Vidarabine	2007
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome	2007
Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Aug-01, Volume: 13, Issue:15 Pt 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Female; Flavonoids; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Piperidines; Prognosis; Remission Induction; Salvage Therapy; Survival Rate	2007
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-01, Volume: 26, Issue:1 Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Radioimmunotherapy; Stem Cell Transplantation; Treatment Outcome; Yttrium Radioisotopes	2008
Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Mar-01, Volume: 14, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Boronic Acids; Bortezomib; Cohort Studies; Cytarabine; Female; Gene Expression Profiling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Oligonucleotide Array Sequence Analysis; Pyrazines; Tissue Distribution; Treatment Outcome	2008
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, May-20, Volume: 26, Issue:15 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa	2008
The treatment of acute lymphoblastic leukaemia (ALL) in childhood, UKALL III: the effects of added cytosine arabinoside and/or asparaginase, and a comparison of continuous or discontinuous mercaptopurine in regimens for standard risk ALL. Medical and pediatric oncology, 1982, Volume: 10, Issue:5 Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow Diseases; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurine; Neoplasm Recurrence, Local; Prognosis; Sex Factors; Testicular Neoplasms; Time Factors	1982
Disseminated nonlymphoblastic lymphoma of childhood: a Childrens Cancer Group study, CCG-552. Medical and pediatric oncology, 1994, Volume: 23, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Humans; Hydrocortisone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Remission Induction; Treatment Outcome; Vincristine	1994
[Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1994, Volume: 35, Issue:9 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Risk; Survival Rate	1994
Stage III abdominal non-Hodgkin's lymphoma in Costa Rican children: comparison of two consecutive trials of treatment. Medical and pediatric oncology, 1994, Volume: 22, Issue:3 Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Child, Preschool; Costa Rica; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Infusions, Intravenous; Leucovorin; Life Tables; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Remission Induction; Survival Rate; Vincristine	1994
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base. Cancer, 1993, Aug-15, Volume: 72, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Ethylnitrosourea; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Thiotepa; Vincristine	1993
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood. Medical and pediatric oncology, 1993, Volume: 21, Issue:2 Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisolone; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine	1993
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. Cancer, 1996, Jun-01, Volume: 77, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Whole-Body Irradiation	1996
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma. Bone marrow transplantation, 1996, Volume: 17, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow Diseases; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Life Tables; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Recombinant Proteins; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation	1996
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Gallium Radioisotopes; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prednisone; Radioimmunodetection; Radiotherapy; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine	1996
All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications. Journal of neuro-oncology, 1997, Volume: 34, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Calcinosis; Cytarabine; Disease Progression; Female; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Radiography; Time Factors; Tretinoin	1997
Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone marrow transplantation, 1997, Volume: 20, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Leukocyte Count; Life Tables; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Proportional Hazards Models; Prospective Studies; Remission Induction; Treatment Outcome	1997
Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM). Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate; Treatment Outcome	1998
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. Blood, 1998, Aug-15, Volume: 92, Issue:4 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Daunorubicin; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Point Mutation; Remission Induction; Tretinoin; Tumor Cells, Cultured	1998
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma. Leukemia & lymphoma, 2000, Volume: 37, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous	2000
Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia. Medical and pediatric oncology, 2000, Volume: 34, Issue:5 Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Marrow Transplantation; Central Nervous System Neoplasms; Child; Child, Preschool; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Injections, Spinal; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine	2000
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Feb-01, Volume: 19, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa	2001
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma. Journal of cancer research and clinical oncology, 2001, Volume: 127, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Drug Resistance, Neoplasm; Feasibility Studies; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy; Survival Rate; Treatment Outcome; Vidarabine	2001
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Feb-01, Volume: 20, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine	2002
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13 Suppl 1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Vinblastine; Vincristine	2002
Prophylactic chemotherapy for primary and recurrent superficial bladder cancer: preliminary results. The Hokkaido University Bladder Cancer Collaborating Group. Cancer chemotherapy and pharmacology, 1992, Volume: 30 Suppl Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Urinary Bladder Neoplasms	1992
BAVC regimen in CR AML patients. Bone marrow transplantation, 1991, Volume: 7 Suppl 2 Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Child, Preschool; Cytarabine; Etoposide; Follow-Up Studies; Graft Survival; Humans; Infant; Italy; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Transplantation, Autologous	1991
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies	1991
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. Journal of neuro-oncology, 1991, Volume: 11, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis	1991
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction; Survival Rate	1991
[Intravesical instillation chemotherapy of anticancer agents including cylocide: studies of prophylactic effects on the recurrence]. Hinyokika kiyo. Acta urologica Japonica, 1990, Volume: 36, Issue:4 Topics: Actuarial Analysis; Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1990
Treatment of relapsed acute lymphocytic leukemia in adults. Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine	1990
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-H Haematology and blood transfusion, 1990, Volume: 33 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Child; Cytarabine; Daunorubicin; Drug Resistance; Germany, West; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prospective Studies; Randomized Controlled Trials as Topic; Thioguanine	1990
Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Lancet (London, England), 1986, Nov-29, Volume: 2, Issue:8518 Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Infant; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Random Allocation; Thioguanine	1986
A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study. Cancer, 1989, Jan-01, Volume: 63, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Humans; Hydrocortisone; Infant; Infant, Newborn; Infections; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Random Allocation; Remission Induction; Vincristine	1989
[Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia]. Presse medicale (Paris, France : 1983), 1987, Feb-07, Volume: 16, Issue:4 Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Drug Resistance; Humans; Infusions, Intravenous; Leukemia; Middle Aged; Neoplasm Recurrence, Local	1987
Isolated central nervous system relapse in acute lymphocytic leukemia (ALL) in children. Experiences of the Swiss Pediatric Oncology Group (SPOG/SAKK) 1976-1986. Helvetica paediatrica acta, 1988, Volume: 43, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Humans; Hydrocortisone; Infant; Injections, Intravenous; Injections, Spinal; Male; Methotrexate; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Switzerland	1988
Overview of the clinical relevance of autologous bone marrow transplantation. Clinics in haematology, 1986, Volume: 15, Issue:1 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Melphalan; Neoplasm Recurrence, Local; Neoplasms; Thioguanine; Transplantation, Autologous	1986
[Cooperative studies in the treatment of acute lymphoblastic leukemia in children in Austria--report of 10 years' experience]. Wiener klinische Wochenschrift, 1985, Feb-01, Volume: 97, Issue:3 Topics: Asparaginase; Austria; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Risk; Vincristine	1985

Other Studies

239 other study(ies) available for cytarabine and Local Neoplasm Recurrence

Article	Year
BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas. Leukemia research, 2021, Volume: 110 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2021
What to use to treat AML: the role of emerging therapies. Hematology. American Society of Hematology. Education Program, 2021, 12-10, Volume: 2021, Issue:1 Topics: Aged; Aminopyridines; Aniline Compounds; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Approval; Drug Discovery; Glycine; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Pyrazines; Pyridines; Triazines	2021
Neutrophil decline rate following autologous transplant for lymphoma is a predictor of patients' outcome. Leukemia & lymphoma, 2022, Volume: 63, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Autografts; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Melphalan; Neoplasm Recurrence, Local; Neutrophils; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous	2022
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone marrow transplantation, 2022, Volume: 57, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cytarabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2022
The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm). British journal of haematology, 2022, Volume: 197, Issue:4 Topics: CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Proteins; Cytarabine; Homoharringtonine; Humans; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Prognosis; Receptors, Colony-Stimulating Factor; Retrospective Studies	2022
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma. British journal of haematology, 2022, Volume: 198, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Salvage Therapy	2022
Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study. Annals of medicine, 2022, Volume: 54, Issue:1 Topics: Cyclophosphamide; Cytarabine; Etoposide; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy, Intensity-Modulated; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation	2022
Survival of patients with mantle cell lymphoma in the rituximab era: Retrospective binational analysis between 2000 and 2020. British journal of haematology, 2023, Volume: 201, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab	2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1. Leukemia, 2023, Volume: 37, Issue:6 Topics: Aged; Cytarabine; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mutation; Neoplasm Recurrence, Local; Nuclear Proteins; Nucleophosmin; Panobinostat	2023
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease. Annals of hematology, 2023, Volume: 102, Issue:7 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Core Binding Factors; Cytarabine; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Treatment Outcome	2023
Real-world treatment and outcome patterns of patients with mantle cell lymphoma in China: A large, multicenter retrospective analysis. Cancer medicine, 2023, Volume: 12, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Treatment Outcome	2023
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. Blood advances, 2023, 08-08, Volume: 7, Issue:15 Topics: Adult; Aged; Bendamustine Hydrochloride; Cytarabine; Follow-Up Studies; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local; Prospective Studies; Rituximab	2023
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies. Clinical lymphoma, myeloma & leukemia, 2023, Volume: 23, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local; Pilot Projects; Rituximab	2023
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH. Blood advances, 2023, 09-26, Volume: 7, Issue:18 Topics: Child; Cladribine; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Neoplasm Recurrence, Local; Proto-Oncogene Proteins B-raf; Vemurafenib	2023
The nutritional impact of CD19-targeted CAR-T therapy versus BEAM chemotherapy for adult patients with lymphoma. Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2023, Volume: 36, Issue:5 Topics: Adult; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Humans; Immunotherapy, Adoptive; Lymphoma; Mucositis; Nausea; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Vomiting; Weight Loss	2023
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas. Leukemia & lymphoma, 2020, Volume: 61, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Recurrence, Local; Oxaliplatin; Retrospective Studies; Rituximab; Salvage Therapy; Stem Cells; Treatment Outcome; Young Adult	2020
BEAM-Modified Conditioning Therapy with Cisplatin+Dexamethasone Instead of Carmustine Prior to Autologous Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hodgkin and Non-Hodgkin Lymphoma. Annals of transplantation, 2019, Oct-22, Volume: 24 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Podophyllotoxin; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2019
FLAG With Bortezomib in Childhood Relapsed/Refractory Leukemia: Remission Induction With Limited Toxicity in the Era of Multidrug-resistant Bacteria. Journal of pediatric hematology/oncology, 2021, 03-01, Volume: 43, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Child; Child, Preschool; Cytarabine; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Vidarabine	2021
Re-induction with modified CLAG regimen in relapsed or refractory acute myeloid leukemia in children bridging to allogeneic hematopoietic stem cell transplantation. World journal of pediatrics : WJP, 2020, Volume: 16, Issue:2 Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cladribine; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Remission Induction; Retreatment; Retrospective Studies	2020
Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. Leukemia & lymphoma, 2020, Volume: 61, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Thioguanine; Treatment Outcome	2020
Hemophagocytic relapsed intramedullary plasmacytoma. International journal of hematology, 2020, Volume: 111, Issue:6 Topics: Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Bortezomib; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Melphalan; Neoplasm Recurrence, Local; Oligopeptides; Plasmacytoma; Positron Emission Tomography Computed Tomography; Pubic Bone; Rare Diseases; Stem Cell Transplantation; Thalidomide; Transplantation, Autologous; Treatment Outcome	2020
Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy. British journal of haematology, 2020, Volume: 189, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Rituximab	2020
Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia. Journal of pediatric hematology/oncology, 2021, 03-01, Volume: 43, Issue:2 Topics: Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; Blood Donors; Clofarabine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Humans; Infant; Lymphocyte Transfusion; Male; Neoplasm Recurrence, Local; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies	2021
Venetoclax is safe and efficacious in relapsed/refractory AML. Leukemia & lymphoma, 2020, Volume: 61, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Retrospective Studies; Sulfonamides	2020
[Effect of Modified LMB 89± Rituximab Regimen on Long-Term Benefits for Patients's with Burkitt Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2020, Volume: 28, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab; Treatment Outcome	2020
A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes. Leukemia research, 2020, Volume: 96 Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Young Adult	2020
The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study. Pediatric blood & cancer, 2021, Volume: 68, Issue:1 Topics: Adolescent; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Transplantation, Homologous; Vidarabine	2021
Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. Journal of feline medicine and surgery, 2021, Volume: 23, Issue:8 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Cytarabine; Lomustine; Lymphoma; Methotrexate; Neoplasm Recurrence, Local	2021
Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma. Acta biomaterialia, 2021, 01-01, Volume: 119 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Lymphoma, Mantle-Cell; Neoplasm Recurrence, Local; Rituximab; Treatment Outcome	2021
Venetoclax + hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia: Two case reports. Medicine, 2020, Nov-20, Volume: 99, Issue:47 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Decitabine; Drug Combinations; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Homoharringtonine; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Sulfonamides; Young Adult	2020
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:4 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Germinal Center; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Progression-Free Survival; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous	2021
Central nervous system relapse of primary cutaneous CD8 British journal of haematology, 2021, Volume: 193, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autografts; CD8-Positive T-Lymphocytes; Central Nervous System; Cranial Nerve Diseases; Cytarabine; Humans; Lymphoma, T-Cell, Cutaneous; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Recurrence; Referral and Consultation; Remission Induction; Skin Neoplasms; Spinal Puncture; Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Treatment Outcome	2021
Role of CD19 and specific KIT-D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities. Cancer medicine, 2021, Volume: 10, Issue:3 Topics: Adolescent; Adult; Aged; Antigens, CD19; Antimetabolites, Antineoplastic; Biomarkers, Tumor; China; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proto-Oncogene Proteins c-kit; Remission Induction; Retrospective Studies; Risk Assessment; Survival Rate; Translocation, Genetic; Young Adult	2021
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol. BMC cancer, 2021, Jan-13, Volume: 21, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Male; Mercaptopurine; Neoplasm Recurrence, Local; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Survival Rate	2021
Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re-induction chemotherapy. Cancer medicine, 2021, Volume: 10, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cladribine; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Induction Chemotherapy; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate	2021
Comment on "Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study." Haematologica, 2021, 04-01, Volume: 106, Issue:4 Topics: Brentuximab Vedotin; Cisplatin; Cytarabine; Dexamethasone; Hodgkin Disease; Humans; Immunoconjugates; Neoplasm Recurrence, Local; Salvage Therapy	2021
Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Cytarabine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Pancytopenia; Retrospective Studies; Salvage Therapy; Survival Rate; Vidarabine; Young Adult	2021
Prognostic factors and their importance in relapsed and refractory AML: Comments on "Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemia" by Linch et al. Leukemia research, 2021, Volume: 105 Topics: Cytarabine; Genotype; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Prognosis	2021
Second Transplant for Relapsed AML, Learning from Defeat. Transplantation and cellular therapy, 2021, Volume: 27, Issue:8 Topics: Cytarabine; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local	2021
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry. Leukemia research, 2021, Volume: 111 Topics: Adult; Aged; Biomarkers, Tumor; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplastic Stem Cells; Prognosis; Retrospective Studies; Young Adult	2021
Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia. Pediatric blood & cancer, 2018, Volume: 65, Issue:1 Topics: Antigens, CD19; Antimetabolites, Antineoplastic; B-Lymphocytes; Bacteriuria; Child; Clofarabine; Cytarabine; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunoglobulin A, Secretory; Immunoglobulin G; Immunoglobulin M; Immunotherapy, Adoptive; Lymphocyte Count; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteus Infections; Proteus mirabilis; Urinary Tract Infections	2018
Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with l-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemia. Leukemia research, 2017, Volume: 62 Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult	2017
Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy. Journal of chemotherapy (Florence, Italy), 2018, Volume: 30, Issue:1 Topics: Adenine Nucleotides; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cytarabine; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Vidarabine; Young Adult	2018
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience. Leukemia & lymphoma, 2018, Volume: 59, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Carmustine; Case-Control Studies; Cytarabine; Diarrhea; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Young Adult	2018
Outcome of relapsed or refractory acute myeloid leukemia treated with intensive salvage chemotherapy in real life in comparison to intermediate dose cytarabine in phase 3 studies. Leukemia & lymphoma, 2019, Volume: 60, Issue:1 Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Analysis; Time Factors; Treatment Outcome	2019
[NAPD regimen for patients with recurrent refractory diffuse large B-cell lymphoma]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018, Jul-28, Volume: 43, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Humans; Induction Chemotherapy; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vinorelbine	2018
[Analysis of Clinical Characteivstics and Therapeutic Efticacy of 54 Patients with Mantle Cell Lymphoma]. Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis	2018
Allogeneic hematopoietic cell transplantation in chemotherapy-induced aplasia in children with high-risk acute myeloid leukemia or myelodysplasia. Pediatric blood & cancer, 2019, Volume: 66, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prognosis; Red-Cell Aplasia, Pure; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2019
A review of R-DHAP administration in the outpatient setting and a case of the alternative regimen R-DHAX given outpatient for refractory diffuse large B-cell lymphoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Outpatients; Oxaliplatin; Rituximab; Salvage Therapy; Thrombocytopenia	2019
Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience. Veterinary and comparative oncology, 2019, Volume: 17, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Dactinomycin; Databases, Factual; Dexamethasone; Dog Diseases; Dogs; Female; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Schools, Veterinary; Thrombocytopenia; Treatment Outcome; United Kingdom	2019
Multimodality therapy for thymoma patients with pleural dissemination. General thoracic and cardiovascular surgery, 2019, Volume: 67, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Female; Humans; Induction Chemotherapy; Lomustine; Male; Middle Aged; Mitoxantrone; Myasthenia Gravis; Neoplasm Recurrence, Local; Pleural Diseases; Pneumonectomy; Prednisone; Retrospective Studies; Survival Rate; Thymoma; Thymus Neoplasms	2019
[Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients]. Revista medica de Chile, 2019, Volume: 147, Issue:1 Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Combined Modality Therapy; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Retrospective Studies; Risk Factors; Rituximab; Sex Distribution; Statistics, Nonparametric; Time Factors; Treatment Outcome	2019
Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report. BMC cancer, 2019, Mar-18, Volume: 19, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Decitabine; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Siblings; Transplantation, Haploidentical; Treatment Outcome	2019
[A Case of Carcinomatous Meningitis Due to Gastric Cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:3 Topics: Adult; Cytarabine; Humans; Male; Meningeal Carcinomatosis; Methotrexate; Neoplasm Recurrence, Local; Stomach Neoplasms	2019
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints. Leukemia, 2019, Volume: 33, Issue:11 Topics: Alleles; Animals; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cytarabine; DNA Damage; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Leukemic; Heterozygote; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Transgenic; Mutation; Myeloid-Lymphoid Leukemia Protein; Neoplasm Recurrence, Local; Nuclear Proteins; Phenotype; Signal Transduction	2019
A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma. Hematological oncology, 2019, Volume: 37, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Induction Chemotherapy; International Cooperation; Lymphoma, Mantle-Cell; Male; Melphalan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Transplantation Conditioning; Treatment Outcome	2019
Rituximab is associated with improved survival for aggressive B cell CNS lymphoma. Neuro-oncology, 2013, Volume: 15, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Cytarabine; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prognosis; Radiotherapy Dosage; Retrospective Studies; Rituximab; Survival Rate; Young Adult	2013
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation. American journal of clinical oncology, 2015, Volume: 38, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustine; Chemoradiotherapy; Cisplatin; Cohort Studies; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vinblastine; Young Adult	2015
Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience. Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Transplantation, Autologous; Young Adult	2013
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood, 2013, Aug-15, Volume: 122, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cyclophosphamide; Cytarabine; Dasatinib; Dexamethasone; Doxorubicin; Female; Flow Cytometry; Follow-Up Studies; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Immunoglobulin Heavy Chains; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Real-Time Polymerase Chain Reaction; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Thiazoles; Vincristine; Young Adult	2013
Rituximab, Ara-C, dexamethasone and oxaliplatin (R-ADOx) is effective for treatment of elderly patients with relapsed mantle cell lymphoma. Journal of cancer research and clinical oncology, 2013, Volume: 139, Issue:10 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Disease-Free Survival; Humans; Kaplan-Meier Estimate; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Rituximab; Treatment Outcome	2013
Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual disease. Leukemia & lymphoma, 2014, Volume: 55, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease Progression; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Treatment Outcome	2014
[Liposomal cytarabine in prophylaxis of the central nervous system involvement in rare aggresive lymphomas]. Przeglad lekarski, 2013, Volume: 70, Issue:4 Topics: Adult; Antimetabolites, Antineoplastic; Burkitt Lymphoma; Central Nervous System Neoplasms; Cytarabine; Drug Carriers; Female; Follow-Up Studies; Humans; Liposomes; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Young Adult	2013
Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia. Leukemia research, 2013, Volume: 37, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Prevalence; Prognosis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Young Adult	2013
Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome. Leukemia research, 2013, Volume: 37, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prevalence; Prognosis; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult	2013
Treatment with cyclophosphamide, vindesine, cytarabine, dexamethasone and bleomycin in patients with relapsed/refractory diffuse large B-cell lymphoma. Leukemia & lymphoma, 2014, Volume: 55, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Retrospective Studies; Treatment Outcome; Vindesine; Young Adult	2014
Sorafenib as monotherapy or in association with cytarabine and clofarabine for the treatment of relapsed/refractory FLT3 ITD-positive advanced acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia, 2014, Volume: 14, Issue:1 Topics: Adenine Nucleotides; Adult; Arabinonucleosides; Clofarabine; Cytarabine; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Sorafenib; Tandem Repeat Sequences; Young Adult	2014
Orbital involvement by non-Hodgkin lymphoma NK T cells. Archivos de la Sociedad Espanola de Oftalmologia, 2014, Volume: 89, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cytarabine; Ethmoid Sinus; Etoposide; Exophthalmos; Fatal Outcome; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Maxillary Sinus; Methylprednisolone; Nasal Obstruction; Neoplasm Recurrence, Local; Orbit; Salvage Therapy; Tomography, X-Ray Computed	2014
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of Cancer, 2014, Mar-15, Volume: 120, Issue:6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Consolidation Chemotherapy; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult	2014
Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia. Pediatric blood & cancer, 2014, Volume: 61, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Melphalan; Neoplasm Recurrence, Local; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2014
Laryngeal chloroma heralding relapse of acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Mar-01, Volume: 32, Issue:7 Topics: Acute Disease; Antimetabolites, Antineoplastic; Cytarabine; Disease Progression; Dose Fractionation, Radiation; Fatal Outcome; Humans; Laryngeal Neoplasms; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Respiratory Insufficiency; Sarcoma, Myeloid; Stem Cell Transplantation; Tomography, X-Ray Computed	2014
Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure. British journal of haematology, 2014, Volume: 165, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome	2014
The percentage of peripheral blood blasts on day 7 of induction chemotherapy predicts response to therapy and survival in patients with acute myeloid leukemia. Chinese medical journal, 2014, Volume: 127, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Cytarabine; Female; Flow Cytometry; Humans; Idarubicin; Immunophenotyping; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Young Adult	2014
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance. Pediatric blood & cancer, 2014, Volume: 61, Issue:9 Topics: Adult; Algorithms; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Mice; Mice, Nude; Neoplasm Recurrence, Local; Oligonucleotide Array Sequence Analysis; Phenylurea Compounds; Precision Medicine; Pyrimidines; Rhabdomyosarcoma, Alveolar; Xenograft Model Antitumor Assays	2014
Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML). Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; DNA Mutational Analysis; Drug Resistance, Neoplasm; Feasibility Studies; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Proto-Oncogene Proteins c-kit; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Young Adult	2014
Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study. Leukemia & lymphoma, 2015, Volume: 56, Issue:3 Topics: Adolescent; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Injections, Spinal; Leukemia, Myeloid, Acute; Liposomes; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies	2015
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party. Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:11 Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; Whole-Body Irradiation; Young Adult	2014
Cytarabine preferentially induces mutation at specific sequences in the genome which are identifiable in relapsed acute myeloid leukaemia. Leukemia, 2015, Volume: 29, Issue:2 Topics: Algorithms; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cytarabine; DNA Mutational Analysis; Humans; Leukemia, Myeloid, Acute; Monte Carlo Method; Mutation; Neoplasm Recurrence, Local; Remission Induction	2015
Sequential development of different acute leukemia types in the same patient. Blood, 2014, Oct-16, Volume: 124, Issue:16 Topics: Acute Disease; Antineoplastic Agents; Cytarabine; Humans; Idarubicin; Leukemia; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local	2014
A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission. International journal of hematology, 2015, Volume: 101, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Male; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Remission Induction; V(D)J Recombination; Vincristine	2015
Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis. Annals of hematology, 2015, Volume: 94, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies	2015
Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:4 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Drug Carriers; Female; Follow-Up Studies; Humans; Injections, Spinal; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Young Adult	2015
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation. International journal of radiation oncology, biology, physics, 2015, May-01, Volume: 92, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Prednisone; Recurrence; Regression Analysis; Risk; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult	2015
Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01. BioMed research international, 2015, Volume: 2015 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Humans; Infant; Male; Methotrexate; Mexico; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk Factors; Treatment Outcome; United States; Vincristine	2015
Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. Blood, 2015, Jul-16, Volume: 126, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult	2015
Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer. TheScientificWorldJournal, 2015, Volume: 2015 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Epirubicin; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome; Urinary Bladder Neoplasms	2015
Successful Treatment With Total Skin Electron Beam Therapy in a Child With Isolated Cutaneous Relapsed AML. Journal of pediatric hematology/oncology, 2015, Volume: 37, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Electrons; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Skin Diseases; Vidarabine	2015
Vosaroxin in acute myeloid leukaemia. The Lancet. Oncology, 2015, Volume: 16, Issue:9 Topics: Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Naphthyridines; Neoplasm Recurrence, Local; Thiazoles	2015
The hypomethylating agent decitabine prior to chemotherapy improves the therapy efficacy in refractory/relapsed acute myeloid leukemia patients. Oncotarget, 2015, Oct-20, Volume: 6, Issue:32 Topics: Aclarubicin; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Line, Tumor; Cytarabine; Decitabine; Disease-Free Survival; Female; Harringtonines; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Young Adult	2015
Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation. Journal of cancer research and clinical oncology, 2016, Volume: 142, Issue:1 Topics: Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult	2016
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT. Journal of hematology & oncology, 2016, Mar-15, Volume: 9 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid; Male; Melphalan; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Transplantation Conditioning; Treatment Outcome	2016
Chemotherapy of mantle cell lymphoma relapsed or refractory chronic lymphocytic leukaemia. Prescrire international, 2016, Volume: 25, Issue:170 Topics: Adenine; Antineoplastic Agents; Bendamustine Hydrochloride; Bortezomib; Chromosomes, Human, Pair 17; Cytarabine; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Mutation; Neoplasm Recurrence, Local; Piperidines; Pyrazoles; Pyrimidines; Rituximab; Sirolimus; Thalidomide; Tumor Suppressor Protein p53; Vidarabine	2016
Utility of post-therapy brain surveillance imaging in the detection of primary central nervous system lymphoma relapse. European journal of cancer (Oxford, England : 1990), 2017, Volume: 72 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Rituximab	2017
Trilateral retinoblastoma with pituitary-hypothalamic dysfunction. Ophthalmic genetics, 2008, Volume: 29, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Fatal Outcome; Female; Gestational Age; Humans; Hypothalamic Diseases; Infant; Infusions, Parenteral; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Retinal Neoplasms; Retinoblastoma; Retinoblastoma Protein; Tomography, X-Ray Computed; Topotecan; Vincristine	2008
Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery, 2008, Volume: 63, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Routes; Drug Administration Schedule; Etoposide; Female; Hemangiopericytoma; Humans; Ifosfamide; Interferon-alpha; Kaplan-Meier Estimate; Liposomes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Rare Diseases; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine	2008
Curative strategies in acute promyelocytic leukemia. Hematology. American Society of Hematology. Education Program, 2008 Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Cytarabine; Daunorubicin; Disease-Free Survival; Growth Inhibitors; History, 20th Century; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasm Recurrence, Local; Oxides; Tretinoin	2008
Pseudohypopyon: Extramedullary relapse of acute myelogenous leukemia with poor prognosis. Pediatric blood & cancer, 2009, Volume: 52, Issue:7 Topics: Anterior Chamber; Antimetabolites, Antineoplastic; Cytarabine; Eye Diseases; Female; Humans; Infant; Injections, Spinal; Leukemia, Myelomonocytic, Acute; Neoplasm Recurrence, Local; Prognosis; Suppuration	2009
Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome	2008
Low dose cytarabine in patients with relapsed or refractory Ewing sarcoma. Pediatric blood & cancer, 2009, Volume: 53, Issue:2 Topics: Adolescent; Antimetabolites, Antineoplastic; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Humans; Male; Neoplasm Recurrence, Local; Sarcoma, Ewing	2009
[Therapeutic management of central nervous system lymphomas in a single hematological institute]. Orvosi hetilap, 2009, Oct-18, Volume: 150, Issue:42 Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Drug Administration Schedule; Epidural Space; Female; Humans; Hungary; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine	2009
Late relapses in acute myeloid leukemia: analysis of characteristics and outcome. Leukemia & lymphoma, 2010, Volume: 51, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Young Adult	2010
An unusual case of acute myeloid leukemia: late isolated testicular relapse followed by isolated central nervous system relapse. Pediatric blood & cancer, 2010, Dec-01, Volume: 55, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Child; Cytarabine; Daunorubicin; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Injections, Spinal; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Testicular Neoplasms; Thioguanine; Treatment Outcome	2010
Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission. Leukemia & lymphoma, 2010, Volume: 51, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Cytogenetic Analysis; Daunorubicin; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Remission Induction; Retrospective Studies; Survival Rate; Transplantation, Homologous; Treatment Outcome; Young Adult	2010
Race and intensity of post-remission therapy in acute myeloid leukemia. Leukemia research, 2011, Volume: 35, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Black People; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Time Factors; Treatment Outcome; White People; Young Adult	2011
FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia. Medical oncology (Northwood, London, England), 2011, Volume: 28 Suppl 1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome; Vidarabine; Young Adult	2011
Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:20 Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Fatal Outcome; Humans; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisone; Rituximab; Vincristine	2010
Salvaging AML with CLAG: novel option, or more of the same? Leukemia research, 2011, Volume: 35, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome	2011
Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens. Leukemia research, 2011, Volume: 35, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Young Adult	2011
Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population. Leukemia & lymphoma, 2011, Volume: 52, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Treatment Outcome; Vincristine; Young Adult	2011
Multifaceted chemotherapy for trilateral retinoblastoma. Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cyclosporine; Cytarabine; Etoposide; Fatal Outcome; Female; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pineal Gland; Retinal Neoplasms; Retinoblastoma; Tomography, X-Ray Computed; Topotecan; Vincristine	2011
Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large-Cell, Anaplastic; Mitoxantrone; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Stem Cell Transplantation; Transplantation, Homologous; Young Adult	2012
An inexpensive way to treat elderly patients with high-risk MDS or AML. Leukemia research, 2011, Volume: 35, Issue:8 Topics: Anemia, Refractory, with Excess of Blasts; Anticonvulsants; Antimetabolites, Antineoplastic; Cytarabine; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Remission Induction; Treatment Outcome; Valproic Acid	2011
Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma. Journal of neuro-oncology, 2011, Volume: 105, Issue:2 Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thiotepa; Young Adult	2011
Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis. German medical science : GMS e-journal, 2011, Volume: 9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Disease-Free Survival; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine; Vindesine	2011
Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma. Journal of pediatric surgery, 2011, Volume: 46, Issue:11 Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Busulfan; Carboplatin; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Male; Melphalan; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neuroblastoma; Peripheral Blood Stem Cell Transplantation; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Vidarabine; Vincristine	2011
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia. Leukemia research, 2012, Volume: 36, Issue:3 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Feasibility Studies; Female; fms-Like Tyrosine Kinase 3; Gene Duplication; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Nuclear Proteins; Nucleophosmin; Prognosis; Real-Time Polymerase Chain Reaction; Remission Induction; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Tandem Repeat Sequences; WT1 Proteins	2012
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy. Anti-cancer drugs, 2012, Volume: 23, Issue:3 Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cerebellar Neoplasms; Cytarabine; Etoposide; Humans; Injections, Spinal; Liposomes; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neutropenia; Pyrazoles; Sulfonamides; Thalidomide; Treatment Outcome	2012
Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot series. Leukemia research, 2012, Volume: 36, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Pilot Projects; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Risk Factors; Rituximab; Salvage Therapy; Survival Rate; Vincristine; Young Adult	2012
Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy. Haematologica, 2012, Volume: 97, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous; Young Adult	2012
FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients. Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Salvage Therapy; Survival Rate; Vidarabine	2012
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. The pharmacogenomics journal, 2013, Volume: 13, Issue:4 Topics: Aminoglycosides; Antibodies, Monoclonal, Humanized; Cytarabine; Enzymes; Female; Gemtuzumab; Genetic Heterogeneity; Genotype; Humans; Idarubicin; Inactivation, Metabolic; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Sialic Acid Binding Ig-like Lectin 3; Treatment Outcome; Vidarabine	2013
Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Clinical biochemistry, 2012, Volume: 45, Issue:16-17 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cytarabine; Daunorubicin; Etoposide; Gene Expression; Gene Expression Regulation, Neoplastic; Hepatomegaly; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Middle Aged; Multivariate Analysis; Muscle Proteins; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-2; Splenomegaly; Treatment Outcome; Up-Regulation; Young Adult	2012
Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse. Haematologica, 2013, Volume: 98, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; In Situ Hybridization; Kaplan-Meier Estimate; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Time Factors; Transplantation, Autologous; Treatment Outcome	2013
Optimal therapy of primary ocular lymphoma. Clinical oncology (Royal College of Radiologists (Great Britain)), 2002, Volume: 14, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Functional Laterality; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Radiotherapy; Vincristine	2002
[Ocular relapse of acute lymphoblastic leukemia]. Bulletin de la Societe belge d'ophtalmologie, 2002, Issue:286 Topics: Administration, Topical; Adrenal Cortex Hormones; Anterior Chamber; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Eye Neoplasms; Fatal Outcome; Humans; Methotrexate; Neoplasm Recurrence, Local; Paracentesis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy, Adjuvant; Vincristine	2002
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma. European journal of haematology, 2003, Volume: 70, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine	2003
Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia. Leukemia, 2003, Volume: 17, Issue:5 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Leukemia, Myeloid; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Treatment Outcome; Vidarabine	2003
Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma. Ophthalmology, 2003, Volume: 110, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Disease-Free Survival; Eye Neoplasms; Humans; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local	2003
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head & neck, 2003, Volume: 25, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis	2003
Salvage chemotherapy according to the ASHAP protocol: a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas. Annals of hematology, 2003, Volume: 82, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Cytarabine; Doxorubicin; Female; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome	2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Nov-15, Volume: 21, Issue:22 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Safety; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome	2003
Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation. Archives of pathology & laboratory medicine, 2004, Volume: 128, Issue:4 Topics: Adult; Aneuploidy; Antigens, CD; Antigens, CD7; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; CD56 Antigen; Cell Size; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; DNA, Neoplasm; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous	2004
Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma. Neurology, 2004, Jul-13, Volume: 63, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Base Sequence; Breast Neoplasms; Clone Cells; Combined Modality Therapy; Cytarabine; DNA, Neoplasm; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Parietal Lobe; Remission Induction; Sequence Alignment; Sequence Homology, Nucleic Acid; Supratentorial Neoplasms; Temporal Lobe	2004
[Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2004, Volume: 23, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Rate; Treatment Outcome; Vincristine	2004
A thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment. Acta medica Okayama, 2004, Volume: 58, Issue:5 Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Epidural Space; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Sarcoma, Myeloid; Spinal Neoplasms; Thoracic Vertebrae	2004
[Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy]. No shinkei geka. Neurological surgery, 2005, Volume: 33, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Cytarabine; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Pulse Therapy, Drug; Radiotherapy, Adjuvant; Remission Induction; Vincristine	2005
[Effects of FLAG regimen in treatment of refractory or relapsed acute myeloid leukemia]. Zhongguo shi yan xue ye xue za zhi, 2005, Volume: 13, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Respiratory Tract Infections; Treatment Outcome; Vidarabine	2005
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome	2005
Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Cytarabine; Dexamethasone; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Salvage Therapy	2005
Granulocytic sarcoma of the heart: extramedullary relapse of acute myeloblastic leukemia after allogeneic stem cell transplantation successfully treated by chemotherapy alone. Leukemia & lymphoma, 2005, Volume: 46, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Heart Neoplasms; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Remission Induction; Sarcoma, Myeloid; Transplantation, Homologous	2005
[Treatment of refractory and relapsed acute lymphocytic leukemia in adults]. Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2005, Aug-18, Volume: 37, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Teniposide; Treatment Outcome; Vidarabine	2005
Molecular response in two children with relapsed acute myeloid leukemia treated with a combination of gemtuzumab ozogamicin and cytarabine. Haematologica, 2006, Volume: 91, Issue:3 Topics: Adolescent; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local	2006
Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Cancer, 2006, Jun-15, Volume: 106, Issue:12 Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Incidence; Lactate Dehydrogenases; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis	2006
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cerebral Ventricle Neoplasms; Combined Modality Therapy; Consciousness Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Etoposide; Female; Gemcitabine; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pituitary Neoplasms; Temozolomide; Thiotepa; Topotecan	2008
PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma. Haematologica, 2006, Volume: 91, Issue:12 Suppl Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Duodenal Neoplasms; Early Diagnosis; Humans; Leukemic Infiltration; Male; Meninges; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Positron-Emission Tomography; Remission Induction; Sarcoma, Myeloid; Transplantation, Homologous	2006
Dexa-BEAM as salvage therapy in patients with primary refractory aggressive non-Hodgkin lymphoma. Leukemia & lymphoma, 2007, Volume: 48, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Autologous	2007
Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment. Human reproduction (Oxford, England), 2007, Volume: 22, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic	2007
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience. Leukemia & lymphoma, 2007, Volume: 48, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine	2007
What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph(+) ALL? Leukemia research, 2007, Volume: 31, Issue:10 Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Cytarabine; Humans; Hydrocortisone; Imatinib Mesylate; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiotherapy; Salvage Therapy	2007
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. American journal of hematology, 2007, Volume: 82, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine	2007
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab]. Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:33 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lymph Nodes; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vinblastine; Vincristine	2007
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jan-10, Volume: 26, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease Progression; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation Conditioning; Treatment Outcome	2008
Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia. Leukemia research, 2008, Volume: 32, Issue:11 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cytarabine; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mesenchymal Stem Cell Transplantation; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Transplantation, Homologous	2008
Cisplatin plus cytosine arabinoside in adults with malignant gliomas. Journal of neuro-oncology, 1984, Volume: 2, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cytarabine; Female; Gastrointestinal Diseases; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local	1984
[Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder; Urinary Bladder Neoplasms	1984
[Anti-tumor effect of intravesical instillation of mitomycin C combined with cytosine arabinoside]. Hinyokika kiyo. Acta urologica Japonica, 1984, Volume: 30, Issue:9 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Staging; Urinary Bladder Neoplasms	1984
Primary lymphoma of the brain: a case report and review of the literature. Journal of surgical oncology, 1984, Volume: 26, Issue:2 Topics: Brain Neoplasms; Cytarabine; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prognosis	1984
Effectiveness of postoperative adjuvant therapy with cytotoxic chemotherapy (cytosine arabinoside, mitomycin C, 5-fluorouracil) or immunotherapy (neuraminidase-modified allogeneic cells) in the prevention of recurrence of Duke's B and C colon cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1981, Volume: 79 Topics: Aged; Colonic Neoplasms; Cytarabine; Female; Fluorouracil; Humans; Immunotherapy; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Neuraminidase; Vaccination	1981
Postoperative prophylactic intravesical instillation of cytosine arabinoside and mitomycin C in superficial bladder tumor. A follow-up study. Urology, 1982, Volume: 20, Issue:5 Topics: Adult; Aged; Cystoscopy; Cytarabine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Time Factors; Urinary Bladder Neoplasms	1982
Advanced and recurrent carcinoma of the ovary treated with a combination of cyclophosphamide, doxorubicin, and cytosine arabinoside. Gynecologic oncology, 1983, Volume: 15, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms	1983
Treatment of acute leukemia in relapse with 4'(9-acridinylamino) methanesulfon-m-anisidide (AMSA) in combination with cytosine arabinoside and thioguanine. Cancer clinical trials, 1981,Fall, Volume: 4, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Neoplasm Recurrence, Local; Thioguanine	1981
Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:3 Topics: Brain Neoplasms; Cytarabine; Humans; Injections, Spinal; Kinetics; Meningeal Neoplasms; Neoplasm Recurrence, Local; Polyamines	1982
Leukemic infiltration of the cerebellum in acute myelomonocytic leukemia. Neurology, 1982, Volume: 32, Issue:1 Topics: Adult; Cerebellar Ataxia; Cerebellar Neoplasms; Cerebellum; Cytarabine; Drug Therapy, Combination; Female; Humans; Injections, Intraventricular; Leukemia, Myeloid, Acute; Methotrexate; Neoplasm Recurrence, Local; Tomography, X-Ray Computed	1982
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours. British journal of urology, 1994, Volume: 74, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Genital Neoplasms, Male; Germinoma; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Time Factors; Vinblastine; Vincristine	1994
Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood, 1995, Apr-15, Volume: 85, Issue:8 Topics: Acute Disease; Adolescent; Adult; Aged; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Blood Cell Count; Bone Marrow; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Gene Expression; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Monosomy; Myelodysplastic Syndromes; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Prognosis; Prospective Studies; Quinine; Remission Induction; Risk; Salvage Therapy; Treatment Outcome	1995
[Pleomorphic T-cell lymphoma. The diagnostic problems, therapeutic possibilities and infection-induced complications]. Deutsche medizinische Wochenschrift (1946), 1993, May-28, Volume: 118, Issue:21 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Humans; Interferon-alpha; Lymphoma, T-Cell, Peripheral; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Remission Induction; Time Factors; Vincristine	1993
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas. Seminars in hematology, 1994, Volume: 31, Issue:2 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Mesna; Methylprednisolone Hemisuccinate; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate	1994
High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease. Annals of hematology, 1993, Volume: 66, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate	1993
[Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:6 Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Remission Induction; Urinary Bladder Neoplasms	1994
Multiagent chemotherapy in the salvage cure of ocular lymphoma relapsing after radiotherapy. Clinical oncology (Royal College of Radiologists (Great Britain)), 1993, Volume: 5, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Eye Neoplasms; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Vincristine	1993
E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Lymphoma; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Treatment Outcome	1993
Late relapse after autologous BMT. Leukemia, 1996, Volume: 10, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Time Factors	1996
Marked bone marrow eosinophilia at the time of relapse of acute myeloblastic leukaemia in association with the appearance of translocation t(12;20)(q24;q11). Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 20; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Eosinophilia; Etoposide; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Remission Induction; Translocation, Genetic	1996
Pediatric leptomeningeal metastases: outcome following combined therapy. Journal of child neurology, 1997, Volume: 12, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid; Chemotherapy, Cancer, Regional Perfusion; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Injections, Intraventricular; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Thiotepa; Treatment Outcome	1997
Spontaneous remission in acute myelogenous leukemia: a case report. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1997, Volume: 59, Issue:2 Topics: Antimetabolites, Antineoplastic; Blood Component Transfusion; Cytarabine; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Remission Induction	1997
Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta neurologica Scandinavica, 1998, Volume: 97, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Follow-Up Studies; Humans; Lymphoma; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Premedication; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine	1998
Proportion of blasts with a clear halo around nucleoli at the end of induction therapy of acute myeloid leukemia correlates with achievement of complete remission, remission duration and relapse. Pathology international, 1998, Volume: 48, Issue:7 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cell Nucleolus; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Leukemia, Myeloid; Mercaptopurine; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Retrospective Studies; Vincristine	1998
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer, 1998, Oct-15, Volume: 83, Issue:8 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Cytarabine; Daunorubicin; Disease Progression; Fatal Outcome; Female; Gene Amplification; Gene Rearrangement; Humans; Idarubicin; Immunophenotyping; Leukemia, Promyelocytic, Acute; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Skin Neoplasms; Translocation, Genetic; Tretinoin	1998
Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. The British journal of ophthalmology, 1999, Volume: 83, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Eye Neoplasms; Female; Humans; Injections; Interleukin-10; Interleukin-6; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Recurrence, Local	1999
[Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:10 Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cytarabine; Daunorubicin; Female; Humans; Injections, Spinal; Leukemia, Promyelocytic, Acute; Neoplasm Recurrence, Local; Remission Induction; Treatment Outcome; Tretinoin	1999
[The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1998, Volume: 51 Suppl 4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Male; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine	1998
Granulocyte macrophage--colony stimulating factor (GM-CSF) as adjunct in induction therapy of acute myeloid leukemia. Indian journal of cancer, 1999, Volume: 36, Issue:1 Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Fever; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction	1999
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen. Cancer, 2000, May-01, Volume: 88, Issue:9 Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cerebellar Diseases; Cytarabine; Death, Sudden, Cardiac; Disease-Free Survival; Drug Eruptions; Exanthema; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome	2000
Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. European journal of haematology, 2000, Volume: 65, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cataract; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infections; Life Tables; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Prognosis; Remission Induction; Retrospective Studies; Survival Analysis; Sweden; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation	2000
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT). British journal of cancer, 2000, Volume: 83, Issue:4 Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine	2000
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). British journal of haematology, 2000, Volume: 110, Issue:2 Topics: Adolescent; Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Regression Analysis; Retrospective Studies; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome	2000
Distinct radiochemotherapy protocols differentially influence cellular proliferation and expression of p53 and Bcl-2 in glioblastoma multiforme relapses in vivo. Journal of neuro-oncology, 2000, Volume: 48, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers; Brain Neoplasms; Cell Division; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, bcl-2; Glioblastoma; GTP-Binding Proteins; Humans; Ki-67 Antigen; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Nimustine; Protein Glutamine gamma Glutamyltransferase 2; Proto-Oncogene Proteins c-bcl-2; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transglutaminases; Tumor Suppressor Protein p53	2000
[Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?]. Revista espanola de medicina nuclear, 2001, Volume: 20, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Follow-Up Studies; Gallium Radioisotopes; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methylprednisolone; Mitoxantrone; Neoplasm Recurrence, Local; Paclitaxel; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Vincristine	2001
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting	2001
Primary central nervous system T-cell lymphoma. Neurology, 2001, Aug-28, Volume: 57, Issue:4 Topics: Adult; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Cytarabine; Fatal Outcome; Humans; Lymphoma, T-Cell; Male; Methotrexate; Neoplasm Recurrence, Local; Prognosis	2001
Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant? Annals of hematology, 2001, Volume: 80, Issue:7 Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors; Transplantation, Autologous; Treatment Outcome	2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease. Blood, 2001, Nov-15, Volume: 98, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine	2001
Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma. Acta haematologica, 2001, Volume: 106, Issue:3 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunologic Factors; Immunotherapy; Interferon-alpha; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Vincristine	2001
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine	2001
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation. Leukemia, 2002, Volume: 16, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Prognosis; Radiopharmaceuticals; Survival Analysis; Survival Rate; Tomography, Emission-Computed; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation	2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study. Leukemia, 2002, Volume: 16, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine	2002
Seven-drug polychemotherapy in the treatment of advanced and recurrent squamous carcinoma of the female genital tract. American journal of obstetrics and gynecology, 1975, Dec-01, Volume: 123, Issue:7 Topics: Adult; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vincristine	1975
Approaches to leukemic relapse following bone marrow transplantation. Transplantation proceedings, 1978, Volume: 10, Issue:1 Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Middle Aged; Mycoses; Neoplasm Recurrence, Local; Thioguanine; Transplantation, Homologous	1978
[Treatment of relapses in juvenile acute lymphoblastic leukemia]. Onkologie, 1978, Volume: 1, Issue:1 Topics: Asparaginase; Blood-Brain Barrier; Blood-Testis Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Meningoencephalitis; Mercaptopurine; Methotrexate; Neoplasm Recurrence, Local; Vincristine	1978
Overexpression of multidrug resistance-associated p170-glycoprotein in acute non-lymphocytic leukemia. European journal of haematology, 1992, Volume: 48, Issue:2 Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow; Cytarabine; Daunorubicin; Drug Resistance; Gene Expression; Humans; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction	1992
Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone ma Blood, 1992, Feb-15, Volume: 79, Issue:4 Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Burkitt Lymphoma; CD24 Antigen; Complement System Proteins; Cyclophosphamide; Cytarabine; Flow Cytometry; Fluorescent Antibody Technique; Humans; Membrane Glycoproteins; Neoplasm Recurrence, Local; Neprilysin; Rabbits; Remission Induction; Tetraspanin 29; Transplantation, Autologous; Tumor Stem Cell Assay; Whole-Body Irradiation	1992
Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia. Acta haematologica, 1992, Volume: 87, Issue:1-2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Humans; Male; Mitoxantrone; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction	1992
Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non-Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL. European journal of haematology, 1991, Volume: 46, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Leukocyte Count; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Vincristine	1991
Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cytarabine; Dexamethasone; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis	1991
Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia. Blood, 1991, May-01, Volume: 77, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Etoposide; Humans; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction	1991
[Effect of etoposide orally administered every other day for the prevention of recurrence of bladder tumor]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:7 Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Postoperative Period; Urinary Bladder Neoplasms	1990
Idarubicin plus attenuated high-dose cytosine arabinoside in the treatment of relapsed and refractory acute leukemia. European journal of haematology, 1990, Volume: 45, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local	1990
Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Doxorubicin; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Neoplasm Recurrence, Local; Prednisolone; Probability; Remission Induction; Vincristine	1990
Pharmacokinetics of cytosine arabinoside in cerebrospinal fluid and of its metabolite in leukemic cells. Medical and pediatric oncology, 1990, Volume: 18, Issue:2 Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Catheterization; Child; Cytarabine; Female; Humans; Hydrocortisone; Injections, Intraventricular; Lumbar Vertebrae; Meningeal Neoplasms; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors	1990
Treatment of relapsed or refractory acute leukemia: comparison of two different regimens. Haematology and blood transfusion, 1990, Volume: 33 Topics: Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Leukemia; Mitoxantrone; Neoplasm Recurrence, Local	1990
High-dose cytosine arabinoside and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia. A retrospective study. Cancer, 1990, Jun-15, Volume: 65, Issue:12 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Retrospective Studies; Survival Rate	1990
Treatment of intraocular lymphoma with high-dose Ara-C. Cancer, 1986, Apr-01, Volume: 57, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Eye Neoplasms; Female; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Palliative Care	1986
Treatment of disseminated germ cell tumours of the testis. British journal of urology, 1989, Volume: 63, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Testis; Vinblastine; Vincristine	1989
High-dose cytosine arabinoside in relapsed and refractory non-Hodgkin's lymphoma. Limited role as a single agent. Cancer, 1989, Nov-15, Volume: 64, Issue:10 Topics: Adult; Aged; Carcinoma, Small Cell; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local	1989
Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone. Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:2 Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Time Factors	1989
[Recurrence or therapeutic resistance of acute myelogenous leukemia. Effect of mitoxantrone and cytosine arabinoside]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1989, Jun-30, Volume: 109, Issue:19-21 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local	1989
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas]. Sangre, 1989, Volume: 34, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Vindesine	1989
Etoposide, dexamethasone, cytarabine, and cisplatin in vincristine, doxorubicin, and dexamethasone-refractory myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Humans; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Vincristine	1989
Poor prognosis of mediastinal non-Hodgkin's lymphoma with an immature phenotype of CD2+, CD7 (or CD5)+, CD3-, CD4-, and CD8-. Cancer, 1989, Feb-15, Volume: 63, Issue:4 Topics: Adolescent; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Phenotype; Prognosis; Remission Induction	1989
Etoposide (VP-16) and cytosine arabinoside in the treatment of relapsed small-cell lung cancer. American journal of clinical oncology, 1988, Volume: 11, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cytarabine; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local	1988
Low-dose cytosine arabinoside as remission induction therapy in refractory adult acute lymphocytic leukemia. The American journal of medicine, 1989, Volume: 86, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction	1989
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methylprednisolone; Neoplasm Recurrence, Local; Procarbazine; Vincristine	1987
Phase II trial of high-dose cytosine arabinoside and cisplatin in recurrent squamous carcinoma of the head and neck. A Piedmont Oncology Association Study. American journal of clinical oncology, 1988, Volume: 11, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cytarabine; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local	1988
[Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method]. Pediatria polska, 1988, Volume: 63, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Thioguanine; Time Factors; Vincristine	1988
[Our experience with combined intravesical instillation therapy of superficial bladder tumor using Aclacinomycin-A (ACM) and cytosine arabinoside (CA)]. Hinyokika kiyo. Acta urologica Japonica, 1987, Volume: 33, Issue:8 Topics: Aclarubicin; Administration, Intravesical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabine; Drug Evaluation; Female; Humans; Male; Middle Aged; Naphthacenes; Neoplasm Recurrence, Local; Remission Induction; Urinary Bladder Neoplasms	1987
[Successful chemotherapy in a primary cerebral centroblastic non-Hodgkin's lymphoma in childhood]. Onkologie, 1986, Volume: 9, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cytarabine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Radioisotope Teletherapy; Tomography, X-Ray Computed	1986
Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias. Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1 Topics: Acute Disease; Asparaginase; Cerebellar Diseases; Cytarabine; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Leukemia; Neoplasm Recurrence, Local	1987
Preliminary results of consolidation therapy with high-dose cytosine arabinoside for patients with bad-risk or relapsed acute leukemia or lymphoblastic non-Hodgkin's lymphoma. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:4 Topics: Acute Disease; Adolescent; Adult; Cytarabine; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Risk	1987
[High-dose cytosine arabinoside therapy in children with non-Hodgkin's lymphoma--effective intensification and CNS prophylaxis]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1987, Volume: 28, Issue:3 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Remission Induction	1987
[High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia]. Sangre, 1987, Volume: 32, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction	1987
Nursing procedures for intraperitoneal administration of cis-platin and Ara-C in the community hospital. Progress in clinical and biological research, 1986, Volume: 216 Topics: Adenocarcinoma; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms	1986
[Prophylactic chemotherapy of transitional cell carcinoma of the bladder: the efficacy of long-term bladder instillation]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1986, Volume: 77, Issue:7 Topics: Administration, Intravesical; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carcinoma, Transitional Cell; Cytarabine; Doxorubicin; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms	1986
Clinical evaluation of high-dose cytarabine and cisplatin in recurrent cervical carcinoma. Cancer treatment reports, 1985, Volume: 69, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Body Temperature; Cisplatin; Creatinine; Cyclophosphamide; Cytarabine; Drug Evaluation; Female; Humans; Leukocyte Count; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platelet Count; Time Factors; Uterine Cervical Neoplasms	1985
Chemotherapy in recurrent heat and neck cancer. Otolaryngologic clinics of North America, 1974, Volume: 7, Issue:1 Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Hydroxyurea; Injections, Intra-Arterial; Injections, Intramuscular; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Vinblastine; Vincristine	1974
Burkitt's lymphoma: cell kinetics, treatment and immunology. Bibliotheca haematologica, 1973, Volume: 39 Topics: Antibodies, Neoplasm; Antibodies, Viral; Burkitt Lymphoma; Culture Techniques; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Herpesvirus 4, Human; Humans; Hypersensitivity, Delayed; Injections, Spinal; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Thymidine; Tritium; Vincristine	1973
Immunological studies on a case of recurrent Burkitt's lymphoma during immune stimulant treatment. International journal of cancer, 1973, Jul-15, Volume: 12, Issue:1 Topics: Antibodies, Neoplasm; Antigen-Antibody Reactions; Antigens, Neoplasm; Antigens, Viral; BCG Vaccine; Burkitt Lymphoma; Cell Membrane; Child, Preschool; Complement Fixation Tests; Cytarabine; Diphtheria Antitoxin; Facial Neoplasms; Herpesvirus 4, Human; Humans; Kidney Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Pertussis Vaccine; Tetanus Antitoxin	1973
Cell cycle changes in ovarian cancer after arabinosylcytosine. Cancer, 1974, Volume: 33, Issue:1 Topics: Adenocarcinoma; Ascites; Ascitic Fluid; Autoradiography; Cell Count; Cell Division; Cell Nucleus; Cell Survival; Cytarabine; Female; Glucose; Humans; Karyotyping; Kinetics; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms	1974
Effect of cyclocytidine on spontaneous mammary adenocarcinoma of mice. Gan, 1974, Volume: 65, Issue:1 Topics: Adenocarcinoma; Anhydrides; Animals; Antineoplastic Agents; Cytarabine; Female; Mammary Neoplasms, Experimental; Mice; Neoplasm Recurrence, Local	1974
Treatment of Burkitt's tumor with cyclophosphamide. Cancer, 1970, Volume: 26, Issue:2 Topics: Abdominal Neoplasms; Adult; Brain Neoplasms; Burkitt Lymphoma; Child; Cranial Nerves; Cyclophosphamide; Cytarabine; Facial Neoplasms; Female; Humans; Injections, Spinal; Male; Mandibular Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Uganda; Vincristine	1970